<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Waldenström's macroglobulinemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Waldenström's_macroglobulinemia","wgTitle":"Waldenström's macroglobulinemia","wgCurRevisionId":670374383,"wgRevisionId":670374383,"wgArticleId":2898867,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with contributors link","Articles that use a Medicine navs subtemplate","Rare cancers","Hematologic malignant neoplasms","Vascular-related cutaneous conditions","Lymphoma"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Waldenström's_macroglobulinemia","wgRelevantArticleId":2898867,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q1778287"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Waldenström_s_macroglobulinemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Waldenström's macroglobulinemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Waldenström's macroglobulinemia</th>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C88.0">C88.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=273.3">273.3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I97613/">9761/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/153600">153600</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb14030.htm">14030</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000588.htm">000588</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic2395.htm">med/2395</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D008258">D008258</a></td>
</tr>
</table>
<p><b>Waldenström's macroglobulinemia</b> (WM, also known as lymphoplasmacytic lymphoma) is cancer affecting <a href="/wiki/B_cells" title="B cells" class="mw-redirect">B cells</a>, a type of <a href="/wiki/White_blood_cell" title="White blood cell">white blood cell</a>. The main attributing antibody is <a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">immunoglobulin M</a> (IgM). WM is an "indolent lymphoma," (i.e., one that tends to grow and spread slowly). It is a type of <a href="/wiki/Lymphoproliferative_disease" title="Lymphoproliferative disease" class="mw-redirect">lymphoproliferative disease</a>, which shares clinical characteristics with the indolent <a href="/wiki/Non-Hodgkin_lymphoma" title="Non-Hodgkin lymphoma">non-Hodgkin lymphomas</a>.<sup id="cite_ref-Cheson_1-0" class="reference"><a href="#cite_note-Cheson-1"><span>[</span>1<span>]</span></a></sup></p>
<p>The disease, named after the Swedish <a href="/wiki/Oncologist" title="Oncologist" class="mw-redirect">oncologist</a> <a href="/wiki/Jan_G._Waldenstr%C3%B6m" title="Jan G. Waldenström">Jan G. Waldenström</a>, was first identified in 1944. As with other lymphomas, the disease is characterized by an uncontrolled increase of <a href="/wiki/B-cells" title="B-cells" class="mw-redirect">B-cells</a>, i.e., white blood cells formed in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> and <a href="/wiki/Lymph_nodes" title="Lymph nodes" class="mw-redirect">lymph nodes</a>. The proliferation of B-cells interferes with the production of <a href="/wiki/Red_blood_cells" title="Red blood cells" class="mw-redirect">red blood cells</a>, resulting in <a href="/wiki/Anemia" title="Anemia">anemia</a>. A unique characteristic of the disease is that the B-cells produce excess amounts of immunoglobulin protein (IgM), thickening the blood, and requiring additional treatment. WM is a rare disease, with only about 1,500 cases per year in the U.S. While the disease is incurable, it is treatable. Because of its indolent nature, many patients are able to lead active lives, and, when treatment is required, may experience years of symptom-free <a href="/wiki/Remission_(medicine)" title="Remission (medicine)" class="mw-redirect">remission</a>.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#History_and_classification"><span class="tocnumber">1</span> <span class="toctext">History and classification</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-4"><a href="#Genetics"><span class="tocnumber">3.1</span> <span class="toctext">Genetics</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Watchful_waiting"><span class="tocnumber">7.1</span> <span class="toctext">Watchful waiting</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#First-line"><span class="tocnumber">7.2</span> <span class="toctext">First-line</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Salvage_therapy"><span class="tocnumber">7.3</span> <span class="toctext">Salvage therapy</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Drug_pipeline"><span class="tocnumber">7.4</span> <span class="toctext">Drug pipeline</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Patient_stratification"><span class="tocnumber">7.5</span> <span class="toctext">Patient stratification</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-14"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Research"><span class="tocnumber">9</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="History_and_classification">History and classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=1" title="Edit section: History and classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>WM was first described by <a href="/wiki/Jan_G._Waldenstr%C3%B6m" title="Jan G. Waldenström">Jan G. Waldenström</a> (1906–1996) in 1944 in two patients with bleeding from the nose and mouth, <a href="/wiki/Anemia" title="Anemia">anemia</a>, decreased levels of <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a> in the blood (hypofibrinogenemia), <a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">swollen lymph nodes</a>, neoplastic plasma cells in bone marrow, and <a href="/wiki/Hyperviscosity_syndrome" title="Hyperviscosity syndrome">increased viscosity of the blood</a> due to increased levels of a class of heavy proteins called <a href="/wiki/Macroglobulins" title="Macroglobulins" class="mw-redirect">macroglobulins</a>.<sup id="cite_ref-Waldenstrom1944_3-0" class="reference"><a href="#cite_note-Waldenstrom1944-3"><span>[</span>3<span>]</span></a></sup></p>
<p>For a time, WM was considered to be related to <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a> due to the presence of <a href="/wiki/Monoclonal_gammopathy" title="Monoclonal gammopathy">monoclonal gammopathy</a> and infiltration of the bone marrow and other organs by plasmacytoid lymphocytes. The new <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) classification, however, places WM under the category of lymphoplasmacytic lymphomas, itself a subcategory of the indolent (low-grade) non-Hodgkin lymphomas.<sup id="cite_ref-Harris_4-0" class="reference"><a href="#cite_note-Harris-4"><span>[</span>4<span>]</span></a></sup> In recent years, there have been significant advances in the understanding and treatment of WM.<sup id="cite_ref-cite_pmid.7C_20040909_5-0" class="reference"><a href="#cite_note-cite_pmid.7C_20040909-5"><span>[</span>5<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Signs and symptoms of WM include <a href="/wiki/Weakness" title="Weakness">weakness</a>, <a href="/wiki/Fatigue_(physical)" title="Fatigue (physical)" class="mw-redirect">fatigue</a>, <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a> and chronic oozing of <a href="/wiki/Epistaxis" title="Epistaxis" class="mw-redirect">blood from the nose</a> and gums.<sup id="cite_ref-Kyle1988_6-0" class="reference"><a href="#cite_note-Kyle1988-6"><span>[</span>6<span>]</span></a></sup> <a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">Peripheral neuropathy</a> can occur in 10% of patients. Lymphadenopathy, enlargement of the <a href="/wiki/Splenomegaly" title="Splenomegaly">spleen</a>, and/or <a href="/wiki/Hepatomegaly" title="Hepatomegaly">liver</a> are present in 30–40% of cases.<sup id="cite_ref-Raje_7-0" class="reference"><a href="#cite_note-Raje-7"><span>[</span>7<span>]</span></a></sup> Other possible signs and symptoms include blurring or loss of vision, headache, and (rarely) <a href="/wiki/Stroke" title="Stroke">stroke</a> or <a href="/wiki/Coma" title="Coma">coma</a>.</p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=3" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Waldenström's macroglobulinemia is characterized by an uncontrolled clonal proliferation of terminally differentiated B lymphocytes. The most common causes are a <a href="/wiki/Somatic_mutation" title="Somatic mutation" class="mw-redirect">somatic mutation</a> in <a href="/wiki/MYD88" title="MYD88">MYD88</a> (90% of patients) and a somatic mutation in <a href="/wiki/CXCR4" title="CXCR4">CXCR4</a> (27% of patients).<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup> There has been an association demonstrated with the locus 6p21.3 on <a href="/wiki/Chromosome_6" title="Chromosome 6" class="mw-redirect">chromosome 6</a>.<sup id="cite_ref-pmid16938573_9-0" class="reference"><a href="#cite_note-pmid16938573-9"><span>[</span>9<span>]</span></a></sup> There is a 2- to 3-fold risk increase of developing WM in people with a personal history of autoimmune diseases with <a href="/wiki/Autoantibodies" title="Autoantibodies" class="mw-redirect">autoantibodies</a> and particularly elevated risks associated with <a href="/wiki/Hepatitis" title="Hepatitis">liver inflammation</a>, <a href="/wiki/Human_immunodeficiency_virus" title="Human immunodeficiency virus" class="mw-redirect">human immunodeficiency virus</a>, and <a href="/wiki/Rickettsiosis" title="Rickettsiosis">rickettsiosis</a>.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<p>There are <a href="/wiki/Genetic_disorder" title="Genetic disorder">genetic factors</a>, with first-degree relatives shown to have a highly increased risk of also contracting Waldenström's.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> There is also evidence to suggest that <a href="/wiki/Environmental_factors" title="Environmental factors" class="mw-redirect">environmental factors</a> including exposure to farming, pesticides, wood dust, and organic solvents may influence the development of Waldenström's.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=4" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Although believed to be a sporadic disease, studies have shown increased susceptibility within families, indicating a genetic component.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> A mutation in gene <a href="/wiki/MYD88" title="MYD88">MYD88</a> has been found to occur frequently in patients.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup> WM cells show only minimal changes in <a href="/wiki/Cytogenetic" title="Cytogenetic" class="mw-redirect">cytogenetic</a> and <a href="/wiki/Gene_expression_profiling" title="Gene expression profiling">gene expression studies</a>. Their <a href="/wiki/MiRNA" title="MiRNA" class="mw-redirect">miRNA</a> signature however differs from their normal counterpart. It is therefore believed that <a href="/wiki/Epigenetics" title="Epigenetics">epigenetic</a> modifications play a crucial role in the disease.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<p><a href="/wiki/Comparative_genomic_hybridization" title="Comparative genomic hybridization">Comparative genomic hybridization</a> identified the following <a href="/wiki/Chromosomal_abnormalities" title="Chromosomal abnormalities" class="mw-redirect">chromosomal abnormalities</a>: deletions of 6q23 and 13q14, and gains of 3q13-q28, 6p and 18q.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/FGFR3" title="FGFR3" class="mw-redirect">FGFR3</a> is overexpressed.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> The following <a href="/wiki/Signalling_pathway" title="Signalling pathway" class="mw-redirect">signalling pathways</a> have been implicated:</p>
<ul>
<li><a href="/wiki/CD154" title="CD154">CD154</a>/<a href="/wiki/CD40" title="CD40" class="mw-redirect">CD40</a><sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup></li>
<li><a href="/wiki/Akt" title="Akt" class="mw-redirect">Akt</a><sup id="cite_ref-20" class="reference"><a href="#cite_note-20"><span>[</span>20<span>]</span></a></sup></li>
<li><a href="/wiki/Ubiquitination" title="Ubiquitination" class="mw-redirect">ubiquitination</a>, <a href="/wiki/P53" title="P53">p53</a> activation, <a href="/wiki/Cytochrome_c" title="Cytochrome c">cytochrome c</a> release<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup></li>
<li><a href="/wiki/NF-%CE%BAB" title="NF-κB">NF-κB</a><sup id="cite_ref-PMID_18334673_22-0" class="reference"><a href="#cite_note-PMID_18334673-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup></li>
<li><a href="/wiki/Wnt_signaling_pathway" title="Wnt signaling pathway">WNT</a>/<a href="/wiki/Beta-catenin" title="Beta-catenin">beta-catenin</a><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></li>
<li><a href="/wiki/MTOR" title="MTOR" class="mw-redirect">mTOR</a><sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></li>
<li><a href="/wiki/Extracellular_signal-regulated_kinases" title="Extracellular signal-regulated kinases">ERK</a><sup id="cite_ref-PMID_18334673_22-1" class="reference"><a href="#cite_note-PMID_18334673-22"><span>[</span>22<span>]</span></a></sup></li>
<li><a href="/wiki/MAPK" title="MAPK" class="mw-redirect">MAPK</a><sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup></li>
<li><a href="/wiki/Bcl-2" title="Bcl-2">Bcl-2</a><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></li>
</ul>
<p>The protein <a href="/wiki/Src_(gene)" title="Src (gene)" class="mw-redirect">Src tyrosine kinase</a> is overexpressed in Waldenström macroglobulinemia cells compared with control B cells.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> Inhibition of Src arrests the <a href="/wiki/Cell_cycle" title="Cell cycle">cell cycle</a> at phase G<sub>1</sub> and has little effect on the survival of WM or normal cells.</p>
<p><a href="/wiki/MicroRNA" title="MicroRNA">MicroRNAs</a> involved in Waldenström's:<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup></p>
<ul>
<li>increased expression of miRNAs-363*,<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> -206,<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> -494,<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span>[</span>33<span>]</span></a></sup> -155,<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup> -184,<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup> -542–3p.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup></li>
<li>decreased expression of miRNA-9*.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></li>
</ul>
<p>MicroRNA-155 regulates the proliferation and growth of WM cells in vitro and in vivo, by inhibiting MAPK/ERK, PI3/AKT, and NF-κB pathways.</p>
<p>In WM-cells, <a href="/wiki/Histone_deacetylase" title="Histone deacetylase">histone deacetylases</a> and histone-modifying genes are de-regulated.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup></p>
<p>Bone marrow tumour cells express the following antigen targets <a href="/wiki/CD20" title="CD20">CD20</a> (98.3%), <a href="/wiki/CD22" title="CD22">CD22</a> (88.3%), <a href="/wiki/CD40" title="CD40" class="mw-redirect">CD40</a> (83.3%), <a href="/wiki/CD52" title="CD52">CD52</a> (77.4%), <a href="/wiki/IgM" title="IgM" class="mw-redirect">IgM</a> (83.3%), <a href="/wiki/MUC1" title="MUC1">MUC1</a> core protein (57.8%), and 1D10 (50%).<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=5" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Symptoms include blurring or loss of vision, headache, and (rarely) <a href="/wiki/Stroke" title="Stroke">stroke</a> or <a href="/wiki/Coma" title="Coma">coma</a> are due to the effects of the <a href="/wiki/IgM" title="IgM" class="mw-redirect">IgM</a> <a href="/wiki/Paraprotein" title="Paraprotein" class="mw-redirect">paraprotein</a>, which may cause <a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a> phenomenon or <a href="/wiki/Cryoglobulinemia" title="Cryoglobulinemia">cryoglobulinemia</a>. Other symptoms of WM are due to the <a href="/wiki/Hyperviscosity_syndrome" title="Hyperviscosity syndrome">hyperviscosity syndrome</a>, which is present in 6-20% of patients.<sup id="cite_ref-Owen_40-0" class="reference"><a href="#cite_note-Owen-40"><span>[</span>40<span>]</span></a></sup><sup id="cite_ref-SanMiguel_41-0" class="reference"><a href="#cite_note-SanMiguel-41"><span>[</span>41<span>]</span></a></sup><sup id="cite_ref-Ghobrial_42-0" class="reference"><a href="#cite_note-Ghobrial-42"><span>[</span>42<span>]</span></a></sup><sup id="cite_ref-Dimopoulos_43-0" class="reference"><a href="#cite_note-Dimopoulos-43"><span>[</span>43<span>]</span></a></sup> This is attributed to the IgM monoclonal protein increasing the viscosity of the blood by forming aggregates to each other, binding water through their carbohydrate component and by their interaction with blood cells.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=6" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>A diagnosis of Waldenström's macroglobulinemia depends on a significant monoclonal IgM spike evident in blood tests and <a href="/wiki/Malignant" title="Malignant" class="mw-redirect">malignant</a> cells consistent with the disease in <a href="/wiki/Bone_marrow_biopsy" title="Bone marrow biopsy" class="mw-redirect">bone marrow biopsy</a> samples.<sup id="cite_ref-workup_45-0" class="reference"><a href="#cite_note-workup-45"><span>[</span>45<span>]</span></a></sup> Blood tests show the level of IgM in the blood and the presence of proteins, or tumor markers, that are the key symptoms of WM. A bone marrow biopsy provides a sample of bone marrow, usually from the back of the pelvis bone. The sample is extracted through a needle and examined under a microscope. A <a href="/wiki/Pathologist" title="Pathologist" class="mw-redirect">pathologist</a> identifies the particular <a href="/wiki/Lymphocytes" title="Lymphocytes" class="mw-redirect">lymphocytes</a> that indicate WM. <a href="/wiki/Flow_cytometry" title="Flow cytometry">Flow cytometry</a> may be used to examine markers on the cell surface or inside the lymphocytes.<sup id="cite_ref-NCIfacts_46-0" class="reference"><a href="#cite_note-NCIfacts-46"><span>[</span>46<span>]</span></a></sup></p>
<p>Additional tests such as <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> (CT or CAT) scan may be used to evaluate the chest, abdomen, and pelvis, particularly swelling of the lymph nodes, liver, and spleen. A skeletal survey can help distinguish between WM and <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>.<sup id="cite_ref-NCIfacts_46-1" class="reference"><a href="#cite_note-NCIfacts-46"><span>[</span>46<span>]</span></a></sup> <a href="/wiki/Anemia" title="Anemia">Anemia</a> is typically found in 80% of patients with WM. A <a href="/wiki/Leukopenia" title="Leukopenia">low white blood cell count</a>, and <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">low platelet count</a> in the blood may be observed. A <a href="/wiki/Neutropenia" title="Neutropenia">low level of neutrophils</a> (a specific type of white blood cell) may also be found in some individuals with WM.<sup id="cite_ref-workup_45-1" class="reference"><a href="#cite_note-workup-45"><span>[</span>45<span>]</span></a></sup></p>
<p>Chemistry tests include <a href="/wiki/Lactate_dehydrogenase" title="Lactate dehydrogenase">lactate dehydrogenase</a> (LDH) levels, uric acid levels, <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR), kidney and liver function, total protein levels, and an albumin-to-globulin ratio. The ESR and <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> level may be <a href="/wiki/Hyperuricemia" title="Hyperuricemia">elevated</a>. Creatinine is occasionally elevated and electrolytes are occasionally abnormal. A <a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">high blood calcium</a> level is noted in approximately 4% of patients. The LDH level is frequently elevated, indicating the extent of Waldenström macroglobulinemia–related tissue involvement. <a href="/wiki/Rheumatoid_factor" title="Rheumatoid factor">Rheumatoid factor</a>, cryoglobulins, direct antiglobulin test and cold agglutinin titre results can be positive. <a href="/wiki/Beta-2_microglobulin" title="Beta-2 microglobulin">Beta-2 microglobulin</a> and <a href="/wiki/C-reactive_protein" title="C-reactive protein">C-reactive protein</a> test results are not specific for Waldenström macroglobulinemia. Beta-2 microglobulin is elevated in proportion to tumor mass. Coagulation abnormalities may be present. <a href="/wiki/Prothrombin_time" title="Prothrombin time">Prothrombin time</a>, <a href="/wiki/Activated_partial_thromboplastin_time" title="Activated partial thromboplastin time" class="mw-redirect">activated partial thromboplastin time</a>, <a href="/wiki/Thrombin_time" title="Thrombin time">thrombin time</a>, and fibrinogen tests should be performed. Platelet aggregation studies are optional. Serum protein electrophoresis results indicate evidence of a monoclonal spike but cannot establish the spike as IgM. An M component with beta-to-gamma mobility is highly suggestive of Waldenström macroglobulinemia. Immunoelectrophoresis and immunofixation studies help identify the type of immunoglobulin, the clonality of the light chain, and the monoclonality and quantitation of the paraprotein. High-resolution electrophoresis and serum and urine immunofixation are recommended to help identify and characterize the monoclonal IgM paraprotein.</p>
<p>The light chain of the monoclonal protein is usually the kappa light chain. At times, patients with Waldenström macroglobulinemia may exhibit more than one M protein. Plasma viscosity must be measured. Results from characterization studies of urinary immunoglobulins indicate that light chains (<a href="/wiki/Bence_Jones_protein" title="Bence Jones protein">Bence Jones protein</a>), usually of the kappa type, are found in the urine. Urine collections should be concentrated.</p>
<p>Bence Jones proteinuria is observed in approximately 40% of patients and exceeds 1 g/d in approximately 3% of patients. Patients with findings of <a href="/wiki/Peripheral_neuropathy" title="Peripheral neuropathy">peripheral neuropathy</a> should have nerve conduction studies and antimyelin associated glycoprotein serology.</p>
<p>Criteria for diagnosis of Waldenstrom macroglobulinemia 1. IgM monoclonal gammopathy that excludes <a href="/wiki/Chronic_lymphocytic_leukemia" title="Chronic lymphocytic leukemia" class="mw-redirect">chronic lymphocytic leukemia</a> and <a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell lymphoma</a> 2. Evidence of anemia, constitutional symptoms, hyperviscosity, <a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">swollen lymph nodes</a>, or <a href="/wiki/Hepatosplenomegaly" title="Hepatosplenomegaly">enlargement of the liver and spleen</a> that can be attributed to an underlying lymphoproliferative disorder.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=7" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Current medical treatments result in survival of some longer than 10 years; in part this is because better diagnostic testing means early diagnosis and treatments. Older diagnosis and treatments resulted in published reports of median survival of approximately 5 years from time of diagnosis.<sup id="cite_ref-Cheson_1-1" class="reference"><a href="#cite_note-Cheson-1"><span>[</span>1<span>]</span></a></sup> Currently, median survival is 6.5 years.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> In rare instances, WM progresses to <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>.<sup id="cite_ref-Johansson_49-0" class="reference"><a href="#cite_note-Johansson-49"><span>[</span>49<span>]</span></a></sup></p>
<p>The International Prognostic Scoring System for Waldenström’s Macroglobulinemia (IPSSWM) is a predictive model to characterise long-term outcome.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup> According to the model, factors predicting survival (n.b. the study quoted conversely refers to them as "5 adverse covariates") are:</p>
<ul>
<li>Age &gt;65 years</li>
<li>Hemoglobin ≤11.5 g/dL</li>
<li>Platelet count ≤100×10<sup>9</sup>/L</li>
<li>B2-microglobulin &gt;3&#160;mg/L</li>
<li>Serum monoclonal protein concentration &gt;70 g/L</li>
</ul>
<p>The risk categories are:</p>
<ul>
<li>Low: ≤1 adverse variable except age</li>
<li>Intermediate: 2 adverse characteristics or age &gt;65 years</li>
<li>High: &gt;2 adverse characteristics</li>
</ul>
<p>Five-year survival rates for these categories are 87%, 68% and 36%, respectively.<sup id="cite_ref-PMID_18641029_52-0" class="reference"><a href="#cite_note-PMID_18641029-52"><span>[</span>52<span>]</span></a></sup></p>
<p>The IPSSWM has been shown to be reliable.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup> It is also applicable to patients on a Rituximab-based treatment regimen.<sup id="cite_ref-PMID_18641029_52-1" class="reference"><a href="#cite_note-PMID_18641029-52"><span>[</span>52<span>]</span></a></sup> An additional predictive factor is elevated serum lactate dehydrogenase (LDH).<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=8" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is no single accepted treatment for WM.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup> There is marked variation in clinical outcome due to gaps in knowledge of the disease's molecular basis. Objective <a href="/wiki/Response_rate" title="Response rate">response rates</a> are high (&gt;80%) but complete response rates are low (0–15%).<sup id="cite_ref-cite_pmid.7C_20040909_5-1" class="reference"><a href="#cite_note-cite_pmid.7C_20040909-5"><span>[</span>5<span>]</span></a></sup> Recently Yang et al. showed that the MYD88 L265P mutation induced activation of <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton's tyrosine kinase">Bruton's tyrosine kinase</a>, the target of the drug <a href="/wiki/Ibrutinib" title="Ibrutinib">ibrutinib</a>. Among previously treated patients ibrutinib induced responses in 91% of patients, and at 2 years 69% of patients had no progression of disease and 95% were alive (Treon et al, New England Journal of Medicine 2015). Based on this study, the FDA approved <a href="/wiki/Ibrutinib" title="Ibrutinib">ibrutinib</a> for use in WM in 2015.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup></p>
<p>There are different treatment flowcharts: Treon<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup> and mSMART.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span>[</span>58<span>]</span></a></sup></p>
<p>WM patients are at higher risk of developing second cancers than the general population, however it is not yet clear whether treatments are contributory.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Watchful_waiting">Watchful waiting</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=9" title="Edit section: Watchful waiting">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the absence of symptoms, many clinicians will recommend simply monitoring the patient.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup> Waldenström himself stated "let well do" referring to watch and wait for patients who can simply be monitored without treatment. But on occasion the disease can be fatal, as it was to the French president <a href="/wiki/Georges_Pompidou" title="Georges Pompidou">Georges Pompidou</a>, who died in office in 1974. The Shah of Iran also suffered from Waldenstrom's Macroglobulinemia which resulted in his ill fated trip to the US for therapy in 1979, leading to the takeover of the US Embassy in Tehran.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="First-line">First-line</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=10" title="Edit section: First-line">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Should treatment be started it should address both the paraprotein level and the lymphocytic B-cells.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></p>
<p>In 2002, a panel at the International Workshop on Waldenström Macroglobulinemia agreed on criteria for the initiation of therapy. They recommended starting therapy in patients with constitutional symptoms such as recurrent <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Night_sweats" title="Night sweats">night sweats</a>, <a href="/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a> due to <a href="/wiki/Anemia" title="Anemia">anemia</a>, <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a>, progressive symptomatic <a href="/wiki/Lymphadenopathy" title="Lymphadenopathy">lymphadenopathy</a> or <a href="/wiki/Splenomegaly" title="Splenomegaly">spleen enlargement</a>, and <a href="/wiki/Anemia" title="Anemia">anemia</a> due to bone marrow infiltration. Complications such as hyperviscosity syndrome, symptomatic sensorimotor peripheral neuropathy, systemic <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a>, <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a>, or symptomatic <a href="/wiki/Cryoglobulinemia" title="Cryoglobulinemia">cryoglobulinemia</a> were also suggested as indications for therapy.<sup id="cite_ref-Kyel2003_63-0" class="reference"><a href="#cite_note-Kyel2003-63"><span>[</span>63<span>]</span></a></sup></p>
<p>Treatment includes the monoclonal antibody <a href="/wiki/Rituximab" title="Rituximab">rituximab</a>, sometimes in combination with chemotherapeutic drugs such as <a href="/wiki/Chlorambucil" title="Chlorambucil">chlorambucil</a>, <a href="/wiki/Cyclophosphamide" title="Cyclophosphamide">cyclophosphamide</a>, or <a href="/wiki/Vincristine" title="Vincristine">vincristine</a> or with <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a>.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup> <a href="/wiki/Corticosteroid" title="Corticosteroid">Corticosteroids</a>, such as <a href="/wiki/Prednisone" title="Prednisone">prednisone</a>, may also be used in combination. <a href="/wiki/Plasmapheresis" title="Plasmapheresis">Plasmapheresis</a> can be used to treat the hyperviscosity syndrome by removing the paraprotein from the blood, although it does not address the underlying disease.<sup id="cite_ref-Gertz_65-0" class="reference"><a href="#cite_note-Gertz-65"><span>[</span>65<span>]</span></a></sup></p>
<p>Recently, autologous <a href="/wiki/Bone_marrow_transplantation" title="Bone marrow transplantation" class="mw-redirect">bone marrow transplantation</a> has been added to the available treatment options.<sup id="cite_ref-Yang_66-0" class="reference"><a href="#cite_note-Yang-66"><span>[</span>66<span>]</span></a></sup><sup id="cite_ref-Martino_67-0" class="reference"><a href="#cite_note-Martino-67"><span>[</span>67<span>]</span></a></sup><sup id="cite_ref-Anagnostopoulos_68-0" class="reference"><a href="#cite_note-Anagnostopoulos-68"><span>[</span>68<span>]</span></a></sup><sup id="cite_ref-Tournilhac_69-0" class="reference"><a href="#cite_note-Tournilhac-69"><span>[</span>69<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Salvage_therapy">Salvage therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=11" title="Edit section: Salvage therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>When primary or secondary <a href="/wiki/Drug_resistance" title="Drug resistance">resistance</a> invariably develops, <a href="/wiki/Salvage_therapy" title="Salvage therapy">salvage therapy</a> is considered. <a href="/wiki/Allogeneic_stem_cell_transplantation" title="Allogeneic stem cell transplantation" class="mw-redirect">Allogeneic stem cell transplantation</a> can induce durable remissions for heavily pre-treated patients.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Drug_pipeline">Drug pipeline</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=12" title="Edit section: Drug pipeline">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>As of October 2010, there have been a total of 44 clinical trials on Waldenstrom's macroglobulinemia, excluding transplantion treatments. Of these, 11 were performed on previously untreated patients, 14 in patients with relapsed or refractory Waldenstrom's.<sup id="cite_ref-71" class="reference"><a href="#cite_note-71"><span>[</span>71<span>]</span></a></sup> A database of clinical trials investigating Waldenström's macroglobulinemia is maintained by the <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a> in the US.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Patient_stratification">Patient stratification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=13" title="Edit section: Patient stratification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Patients with <a href="/wiki/Polymorphism_(biology)" title="Polymorphism (biology)">polymorphic variants</a> (<a href="/wiki/Alleles" title="Alleles" class="mw-redirect">alleles</a>) <a href="/wiki/FCGR3A" title="FCGR3A">FCGR3A</a>-48 and -158 were associated with improved categorical responses to Rituximab-based treatments.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=14" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Of all <a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">cancers involving the lymphocytes</a>, 1% of cases are WM.<sup id="cite_ref-isbn0-7817-5007-5_74-0" class="reference"><a href="#cite_note-isbn0-7817-5007-5-74"><span>[</span>74<span>]</span></a></sup></p>
<p>WM is a rare disorder, with fewer than 1,500 cases occurring in the United States annually.<sup id="cite_ref-Cheson_1-2" class="reference"><a href="#cite_note-Cheson-1"><span>[</span>1<span>]</span></a></sup> The median age of onset of WM is between 60 and 65 years, with some cases occurring in late teens.<sup id="cite_ref-Cheson_1-3" class="reference"><a href="#cite_note-Cheson-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Raje_7-1" class="reference"><a href="#cite_note-Raje-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=15" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>One recent investigation showed that a population of cells, lacking both B-cell and plasma cell markers, has characteristics of <a href="/wiki/Cancer_stem_cells" title="Cancer stem cells" class="mw-redirect">cancer-initiating cells</a> in Waldenstrom macroglobulinemia.<sup id="cite_ref-pmid_.3D_24189269_75-0" class="reference"><a href="#cite_note-pmid_.3D_24189269-75"><span>[</span>75<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=16" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Waldenstr%C3%B6m_hyperglobulinemic_purpura" title="Waldenström hyperglobulinemic purpura">Waldenström hyperglobulinemic purpura</a></li>
<li><a href="/wiki/List_of_hematologic_conditions" title="List of hematologic conditions">List of hematologic conditions</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=17" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Cheson-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cheson_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cheson_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cheson_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Cheson_1-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Cheson BD (2006). "Chronic Lymphoid Leukemias and Plasma Cell Disorders". In Dale DD, Federman DD. <i>ACP Medicine</i>. New York, NY: WebMD Professional Publishing. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-9748327-1-5" title="Special:BookSources/0-9748327-1-5">0-9748327-1-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Chronic+Lymphoid+Leukemias+and+Plasma+Cell+Disorders&amp;rft.au=Cheson+BD&amp;rft.aulast=Cheson+BD&amp;rft.btitle=ACP+Medicine&amp;rft.date=2006&amp;rft.genre=bookitem&amp;rft.isbn=0-9748327-1-5&amp;rft.place=New+York%2C+NY&amp;rft.pub=WebMD+Professional+Publishing&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text">International Waldenstrom's Macroglobulinemia Foundation (IWMF). "Living with Waldenstrom's Macroglobulinemia."</span></li>
<li id="cite_note-Waldenstrom1944-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-Waldenstrom1944_3-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Waldenstrom J (1944). "Incipient myelomatosis or "essential" hyperglobulinemia with fibrinognenopenia-a new syndrome?". <i>Acta Med Scand</i> <b>117</b> (3–4): 216–247. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.0954-6820.1944.tb03955.x">10.1111/j.0954-6820.1944.tb03955.x</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Incipient+myelomatosis+or+%22essential%22+hyperglobulinemia+with+fibrinognenopenia-a+new+syndrome%3F&amp;rft.aulast=Waldenstrom+J&amp;rft.au=Waldenstrom+J&amp;rft.date=1944&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.0954-6820.1944.tb03955.x&amp;rft.issue=3%E2%80%934&amp;rft.jtitle=Acta+Med+Scand&amp;rft.pages=216-247&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=117" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Harris-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-Harris_4-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000). "The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997". <i>Histopathology</i> <b>36</b> (1): 69–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2559.2000.00895.x">10.1046/j.1365-2559.2000.00895.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10632755">10632755</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=The+World+Health+Organization+classification+of+neoplastic+diseases+of+the+haematopoietic+and+lymphoid+tissues%3A+Report+of+the+Clinical+Advisory+Committee+Meeting%2C+Airlie+House%2C+Virginia%2C+November+1997&amp;rft.au=Harris+NL%2C+Jaffe+ES%2C+Diebold+J%2C+Flandrin+G%2C+Muller-Hermelink+HK%2C+Vardiman+J%2C+Lister+TA%2C+Bloomfield+CD&amp;rft.aulast=Harris+NL%2C+Jaffe+ES%2C+Diebold+J%2C+Flandrin+G%2C+Muller-Hermelink+HK%2C+Vardiman+J%2C+Lister+TA%2C+Bloomfield+CD&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2559.2000.00895.x&amp;rft_id=info%3Apmid%2F10632755&amp;rft.issue=1&amp;rft.jtitle=Histopathology&amp;rft.pages=69-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-cite_pmid.7C_20040909-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-cite_pmid.7C_20040909_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cite_pmid.7C_20040909_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Neparidze, N.; Dhodapkar, M. (2009). "Waldenstrom's macroglobulinemia: Recent advances in biology and therapy". <i>Clinical advances in hematology &amp; oncology&#160;: H&amp;O</i> <b>7</b> (10): 677–681, 687–681. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20040909">20040909</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Waldenstrom%27s+macroglobulinemia%3A+Recent+advances+in+biology+and+therapy&amp;rft.au=Dhodapkar%2C+M.&amp;rft.aufirst=N.&amp;rft.aulast=Neparidze&amp;rft.au=Neparidze%2C+N.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F20040909&amp;rft.issue=10&amp;rft.jtitle=Clinical+advances+in+hematology+%26+oncology+%3A+H%26O&amp;rft.pages=677-681%2C+687-681&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20040909&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-Kyle1988-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kyle1988_6-0">^</a></b></span> <span class="reference-text"><span class="citation book">Kyle RA (1998). "Chapter 94: Multiple Myeloma and the Dysproteinemias". In Stein JH. <i>Internal Medicine</i> (5th ed.). New York: C.V.Mosby. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-8151-8698-3" title="Special:BookSources/0-8151-8698-3">0-8151-8698-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Chapter+94%3A+Multiple+Myeloma+and+the+Dysproteinemias&amp;rft.au=Kyle+RA&amp;rft.aulast=Kyle+RA&amp;rft.btitle=Internal+Medicine&amp;rft.date=1998&amp;rft.edition=5th&amp;rft.genre=bookitem&amp;rft.isbn=0-8151-8698-3&amp;rft.place=New+York&amp;rft.pub=C.V.Mosby&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Raje-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Raje_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Raje_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Raje N, Hideshima T, Anderson KC (2003). "Plasma Cell Tumors". In Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS. <i>Holland-Frei Cancer Medicine</i> (6th ed.). New York, NY: B.C. Decker. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-55009-213-8" title="Special:BookSources/1-55009-213-8">1-55009-213-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Plasma+Cell+Tumors&amp;rft.aulast=Raje+N%2C+Hideshima+T%2C+Anderson+KC&amp;rft.au=Raje+N%2C+Hideshima+T%2C+Anderson+KC&amp;rft.btitle=Holland-Frei+Cancer+Medicine&amp;rft.date=2003&amp;rft.edition=6th&amp;rft.genre=bookitem&amp;rft.isbn=1-55009-213-8&amp;rft.place=New+York%2C+NY&amp;rft.pub=B.C.+Decker&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Hunter, Z. R.; Xu, L.; Yang, G.; Zhou, Y.; Liu, X.; Cao, Y.; Manning, R. J.; Tripsas, C.; Patterson, C. J.; Sheehy, P.; Treon, S. P. (2013). "The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis". <i>Blood</i> <b>123</b> (11): 1637. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2013-09-525808">10.1182/blood-2013-09-525808</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=The+genomic+landscape+of+Waldenstrom+macroglobulinemia+is+characterized+by+highly+recurring+MYD88+and+WHIM-like+CXCR4+mutations%2C+and+small+somatic+deletions+associated+with+B-cell+lymphomagenesis&amp;rft.au=Cao%2C+Y.&amp;rft.aufirst=Z.+R.&amp;rft.au=Hunter%2C+Z.+R.&amp;rft.aulast=Hunter&amp;rft.au=Liu%2C+X.&amp;rft.au=Manning%2C+R.+J.&amp;rft.au=Patterson%2C+C.+J.&amp;rft.au=Sheehy%2C+P.&amp;rft.au=Treon%2C+S.+P.&amp;rft.au=Tripsas%2C+C.&amp;rft.au=Xu%2C+L.&amp;rft.au=Yang%2C+G.&amp;rft.au=Zhou%2C+Y.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2013-09-525808&amp;rft.issue=11&amp;rft.jtitle=Blood&amp;rft.pages=1637&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=123" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1182.2Fblood-2013-09-525808&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-pmid16938573-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16938573_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Schop, Roelandt F.J.; Van Wier, Scott A.; Xu, Ruifang et al. (2006). "6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance". <i>Cancer Genet. Cytogenet.</i> <b>169</b> (2): 150–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.cancergencyto.2006.04.009">10.1016/j.cancergencyto.2006.04.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16938573">16938573</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=6q+deletion+discriminates+Waldenstr%C3%B6m+macroglobulinemia+from+IgM+monoclonal+gammopathy+of+undetermined+significance&amp;rft.au=Ahmann%2C+G.&amp;rft.au=Dispenzieri%2C+A.&amp;rft.aufirst=Roelandt+F.J.&amp;rft.au=Fonseca%2C+R.&amp;rft.au=Gertz%2C+M.&amp;rft.au=Ghobrial%2C+I.&amp;rft.au=Greipp%2C+P.&amp;rft.au=Kyle%2C+R.&amp;rft.au=Lacy%2C+M.&amp;rft.aulast=Schop&amp;rft.au=Rajkumar%2C+S.&amp;rft.au=Schop%2C+Roelandt+F.J.&amp;rft.au=Van+Wier%2C+Scott+A.&amp;rft.au=Xu%2C+Ruifang&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cancergencyto.2006.04.009&amp;rft_id=info%3Apmid%2F16938573&amp;rft.issue=2&amp;rft.jtitle=Cancer+Genet.+Cytogenet.&amp;rft.pages=150-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=169" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Koshiol, J.; Gridley, G.; Engels, E.; McMaster, M.; Landgren, O. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2670401">"Chronic immune stimulation and subsequent Waldenström macroglobulinemia"</a>. <i>Archives of Internal Medicine</i> <b>168</b> (17): 1903–1909. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinternmed.2008.4">10.1001/archinternmed.2008.4</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2670401">2670401</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18809818">18809818</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Chronic+immune+stimulation+and+subsequent+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Engels%2C+E.&amp;rft.aufirst=J.&amp;rft.au=Gridley%2C+G.&amp;rft.au=Koshiol%2C+J.&amp;rft.au=Landgren%2C+O.&amp;rft.aulast=Koshiol&amp;rft.au=McMaster%2C+M.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2670401&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2008.4&amp;rft_id=info%3Apmc%2F2670401&amp;rft_id=info%3Apmid%2F18809818&amp;rft.issue=17&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.pages=1903-1909&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=168" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18809818&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Kristinsson, S.; Björkholm, M.; Goldin, L.; McMaster, M.; Turesson, I.; Landgren, O. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2569164">"Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden"</a>. <i>Blood</i> <b>112</b> (8): 3052–3056. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-06-162768">10.1182/blood-2008-06-162768</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2569164">2569164</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18703425">18703425</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Risk+of+lymphoproliferative+disorders+among+first-degree+relatives+of+lymphoplasmacytic+lymphoma%2FWaldenstrom+macroglobulinemia+patients%3A+a+population-based+study+in+Sweden&amp;rft.au=Bj%C3%B6rkholm%2C+M.&amp;rft.aufirst=S.&amp;rft.au=Goldin%2C+L.&amp;rft.au=Kristinsson%2C+S.&amp;rft.au=Landgren%2C+O.&amp;rft.aulast=Kristinsson&amp;rft.au=McMaster%2C+M.&amp;rft.au=Turesson%2C+I.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2569164&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-06-162768&amp;rft_id=info%3Apmc%2F2569164&amp;rft_id=info%3Apmid%2F18703425&amp;rft.issue=8&amp;rft.jtitle=Blood&amp;rft.pages=3052-3056&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18703425&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Royer, R.; Koshiol, J.; Giambarresi, T.; Vasquez, L.; Pfeiffer, R.; McMaster, M. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2881498">"Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation"</a>. <i>Blood</i> <b>115</b> (22): 4464–4471. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2009-10-247973">10.1182/blood-2009-10-247973</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2881498">2881498</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20308603">20308603</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Differential+characteristics+of+Waldenstr%C3%B6m+macroglobulinemia+according+to+patterns+of+familial+aggregation&amp;rft.aufirst=R.&amp;rft.au=Giambarresi%2C+T.&amp;rft.au=Koshiol%2C+J.&amp;rft.aulast=Royer&amp;rft.au=McMaster%2C+M.&amp;rft.au=Pfeiffer%2C+R.&amp;rft.au=Royer%2C+R.&amp;rft.au=Vasquez%2C+L.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2881498&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-10-247973&amp;rft_id=info%3Apmc%2F2881498&amp;rft_id=info%3Apmid%2F20308603&amp;rft.issue=22&amp;rft.jtitle=Blood&amp;rft.pages=4464-4471&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=115" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20308603&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">McMaster, M. (2003). "Familial Waldenstrom's macroglobulinemia". <i>Seminars in oncology</i> <b>30</b> (2): 146–152. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50063">10.1053/sonc.2003.50063</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720125">12720125</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Familial+Waldenstrom%27s+macroglobulinemia&amp;rft.aufirst=M.&amp;rft.aulast=McMaster&amp;rft.au=McMaster%2C+M.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50063&amp;rft_id=info%3Apmid%2F12720125&amp;rft.issue=2&amp;rft.jtitle=Seminars+in+oncology&amp;rft.pages=146-152&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/12720125&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">McMaster, M.; Goldin, L.; Bai, Y.; Ter-Minassian, M.; Boehringer, S.; Giambarresi, T.; Vasquez, L.; Tucker, M. (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1592553">"Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families"</a>. <i>American Journal of Human Genetics</i> <b>79</b> (4): 695–701. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1086%2F507687">10.1086/507687</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1592553">1592553</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16960805">16960805</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Genomewide+linkage+screen+for+Waldenstrom+macroglobulinemia+susceptibility+loci+in+high-risk+families&amp;rft.au=Bai%2C+Y.&amp;rft.au=Boehringer%2C+S.&amp;rft.aufirst=M.&amp;rft.au=Giambarresi%2C+T.&amp;rft.au=Goldin%2C+L.&amp;rft.aulast=McMaster&amp;rft.au=McMaster%2C+M.&amp;rft.au=Ter-Minassian%2C+M.&amp;rft.au=Tucker%2C+M.&amp;rft.au=Vasquez%2C+L.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1592553&amp;rft_id=info%3Adoi%2F10.1086%2F507687&amp;rft_id=info%3Apmc%2F1592553&amp;rft_id=info%3Apmid%2F16960805&amp;rft.issue=4&amp;rft.jtitle=American+Journal+of+Human+Genetics&amp;rft.pages=695-701&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1086.2F507687&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Treon, S. P.; Xu, L.; Yang, G.; Zhou, Y.; Liu, X.; Cao, Y.; Sheehy, P.; Manning, R. J.; Patterson, C. J.; Tripsas, C.; Arcaini, L.; Pinkus, G. S.; Rodig, S. J.; Sohani, A. R.; Harris, N. L.; Laramie, J. M.; Skifter, D. A.; Lincoln, S. E.; Hunter, Z. R. (2012). "MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia". <i>New England Journal of Medicine</i> <b>367</b> (9): 826–833. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1200710">10.1056/NEJMoa1200710</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22931316">22931316</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=MYD88+L265P+Somatic+Mutation+in+Waldenstr%C3%B6m%27s+Macroglobulinemia&amp;rft.au=Arcaini%2C+L.&amp;rft.au=Cao%2C+Y.&amp;rft.aufirst=S.+P.&amp;rft.au=Harris%2C+N.+L.&amp;rft.au=Hunter%2C+Z.+R.&amp;rft.au=Laramie%2C+J.+M.&amp;rft.aulast=Treon&amp;rft.au=Lincoln%2C+S.+E.&amp;rft.au=Liu%2C+X.&amp;rft.au=Manning%2C+R.+J.&amp;rft.au=Patterson%2C+C.+J.&amp;rft.au=Pinkus%2C+G.+S.&amp;rft.au=Rodig%2C+S.+J.&amp;rft.au=Sheehy%2C+P.&amp;rft.au=Skifter%2C+D.+A.&amp;rft.au=Sohani%2C+A.+R.&amp;rft.au=Treon%2C+S.+P.&amp;rft.au=Tripsas%2C+C.&amp;rft.au=Xu%2C+L.&amp;rft.au=Yang%2C+G.&amp;rft.au=Zhou%2C+Y.&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1200710&amp;rft_id=info%3Apmid%2F22931316&amp;rft.issue=9&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=826-833&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=367" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/22931316&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Sacco, A.; Issa, G. C.; Zhang, Y.; Liu, Y.; Maiso, P.; Ghobrial, I. M.; Roccaro, A. M. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2964547">"Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology"</a>. <i>Journal of Hematology &amp; Oncology</i> <b>3</b>: 38. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1756-8722-3-38">10.1186/1756-8722-3-38</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2964547">2964547</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20929526">20929526</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Epigenetic+modifications+as+key+regulators+of+Waldenstrom%27s+Macroglobulinemia+biology&amp;rft.aufirst=A.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Issa%2C+G.+C.&amp;rft.aulast=Sacco&amp;rft.au=Liu%2C+Y.&amp;rft.au=Maiso%2C+P.&amp;rft.au=Roccaro%2C+A.+M.&amp;rft.au=Sacco%2C+A.&amp;rft.au=Zhang%2C+Y.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2964547&amp;rft_id=info%3Adoi%2F10.1186%2F1756-8722-3-38&amp;rft_id=info%3Apmc%2F2964547&amp;rft_id=info%3Apmid%2F20929526&amp;rft.jtitle=Journal+of+Hematology+%26+Oncology&amp;rft.pages=38&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1186.2F1756-8722-3-38&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Braggio, E.; Keats, J. J.; Leleu, X.; Van Wier, S. V.; Jimenez-Zepeda, V. H.; Schop, R. F. J.; Chesi, M.; Barrett, M.; Stewart, A. K.; Dogan, A.; Bergsagel, P. L.; Ghobrial, I. M.; Fonseca, R. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3646570">"High-Resolution Genomic Analysis in Waldenström's Macroglobulinemia Identifies Disease-Specific and Common Abnormalities with Marginal Zone Lymphomas"</a>. <i>Clinical Lymphoma, Myeloma &amp; Leukemia</i> <b>9</b> (1): 39–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3816%2FCLM.2009.n.009">10.3816/CLM.2009.n.009</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3646570">3646570</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19362969">19362969</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=High-Resolution+Genomic+Analysis+in+Waldenstr%C3%B6m%27s+Macroglobulinemia+Identifies+Disease-Specific+and+Common+Abnormalities+with+Marginal+Zone+Lymphomas&amp;rft.au=Barrett%2C+M.&amp;rft.au=Bergsagel%2C+P.+L.&amp;rft.au=Braggio%2C+E.&amp;rft.au=Chesi%2C+M.&amp;rft.au=Dogan%2C+A.&amp;rft.aufirst=E.&amp;rft.au=Fonseca%2C+R.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Jimenez-Zepeda%2C+V.+H.&amp;rft.au=Keats%2C+J.+J.&amp;rft.aulast=Braggio&amp;rft.au=Leleu%2C+X.&amp;rft.au=Schop%2C+R.+F.+J.&amp;rft.au=Stewart%2C+A.+K.&amp;rft.au=Van+Wier%2C+S.+V.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3646570&amp;rft_id=info%3Adoi%2F10.3816%2FCLM.2009.n.009&amp;rft_id=info%3Apmc%2F3646570&amp;rft_id=info%3Apmid%2F19362969&amp;rft.issue=1&amp;rft.jtitle=Clinical+Lymphoma%2C+Myeloma+%26+Leukemia&amp;rft.pages=39-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19362969&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Azab, A. K.; Azab, F.; Quang, P.; Maiso, P.; Sacco, B.; Ngo, A.; Liu, H. T.; Zhang, Y.; Morgan, Y.; Roccaro, A. M.; Ghobrial, I. M. (2011). "FGFR3 is overexpressed Waldenstrom macroglobulinemia and its inhibition by Dovitinib induces apoptosis, and overcomes stroma-induced proliferation". <i>Clinical Cancer Research</i> <b>17</b> (13): 4389–4399. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-10-2772">10.1158/1078-0432.CCR-10-2772</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21521775">21521775</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=FGFR3+is+overexpressed+Waldenstrom+macroglobulinemia+and+its+inhibition+by+Dovitinib+induces+apoptosis%2C+and+overcomes+stroma-induced+proliferation&amp;rft.au=Azab%2C+A.+K.&amp;rft.au=Azab%2C+F.&amp;rft.aufirst=A.+K.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.aulast=Azab&amp;rft.au=Liu%2C+H.+T.&amp;rft.au=Maiso%2C+P.&amp;rft.au=Morgan%2C+Y.&amp;rft.au=Ngo%2C+A.&amp;rft.au=Quang%2C+P.&amp;rft.au=Roccaro%2C+A.+M.&amp;rft.au=Sacco%2C+B.&amp;rft.au=Zhang%2C+Y.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-2772&amp;rft_id=info%3Apmid%2F21521775&amp;rft.issue=13&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.pages=4389-4399&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/21521775&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.asco.org/ASCO/Abstracts+&amp;+Virtual+Meeting/Abstracts?&amp;vmview=abst_detail_view&amp;confID=26&amp;abstractID=4297">http://www.asco.org/ASCO/Abstracts+&amp;+Virtual+Meeting/Abstracts?&amp;vmview=abst_detail_view&amp;confID=26&amp;abstractID=4297</a></span></li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><span class="citation journal">Leleu, X.; Jia, X.; Runnels, J.; Ngo, H.; Moreau, A.; Farag, M.; Spencer, J.; Pitsillides, C.; Hatjiharissi, E.; Roccaro, A.; O'Sullivan, G.; McMillin, D. W.; Moreno, D.; Kiziltepe, T.; Carrasco, R.; Treon, S. P.; Hideshima, T.; Anderson, K. C.; Lin, C. P.; Ghobrial, I. M. (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2234792">"The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia"</a>. <i>Blood</i> <b>110</b> (13): 4417–4426. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-05-092098">10.1182/blood-2007-05-092098</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2234792">2234792</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17761832">17761832</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=The+Akt+pathway+regulates+survival+and+homing+in+Waldenstrom+macroglobulinemia&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Carrasco%2C+R.&amp;rft.au=Farag%2C+M.&amp;rft.aufirst=X.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Hatjiharissi%2C+E.&amp;rft.au=Hideshima%2C+T.&amp;rft.au=Jia%2C+X.&amp;rft.au=Kiziltepe%2C+T.&amp;rft.aulast=Leleu&amp;rft.au=Leleu%2C+X.&amp;rft.au=Lin%2C+C.+P.&amp;rft.au=McMillin%2C+D.+W.&amp;rft.au=Moreau%2C+A.&amp;rft.au=Moreno%2C+D.&amp;rft.au=Ngo%2C+H.&amp;rft.au=O%27Sullivan%2C+G.&amp;rft.au=Pitsillides%2C+C.&amp;rft.au=Roccaro%2C+A.&amp;rft.au=Runnels%2C+J.&amp;rft.au=Spencer%2C+J.&amp;rft.au=Treon%2C+S.+P.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2234792&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-05-092098&amp;rft_id=info%3Apmc%2F2234792&amp;rft_id=info%3Apmid%2F17761832&amp;rft.issue=13&amp;rft.jtitle=Blood&amp;rft.pages=4417-4426&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=110" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1182.2Fblood-2007-05-092098&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Mensah-Osman, E.; Al-Katib, A.; Dandashi, M.; Mohammad, R. (2003). "XK469, a topo IIbeta inhibitor, induces apoptosis in Waldenstrom's macroglobulinemia through multiple pathways". <i>International journal of oncology</i> <b>23</b> (6): 1637–1644. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3892%2Fijo.23.6.1637">10.3892/ijo.23.6.1637</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14612935">14612935</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=XK469%2C+a+topo+IIbeta+inhibitor%2C+induces+apoptosis+in+Waldenstrom%27s+macroglobulinemia+through+multiple+pathways&amp;rft.au=Al-Katib%2C+A.&amp;rft.au=Dandashi%2C+M.&amp;rft.aufirst=E.&amp;rft.aulast=Mensah-Osman&amp;rft.au=Mensah-Osman%2C+E.&amp;rft.au=Mohammad%2C+R.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3892%2Fijo.23.6.1637&amp;rft_id=info%3Apmid%2F14612935&amp;rft.issue=6&amp;rft.jtitle=International+journal+of+oncology&amp;rft.pages=1637-1644&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/14612935&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-PMID_18334673-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMID_18334673_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMID_18334673_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Leleu, X.; Eeckhoute, J.; Jia, X.; Roccaro, A.; Moreau, A.; Farag, M.; Sacco, A.; Ngo, H.; Runnels, J.; Melhem, M. R.; Burwick, N.; Azab, A.; Azab, F.; Hunter, Z.; Hatjiharissi, E.; Carrasco, D. R.; Treon, S. P.; Witzig, T. E.; Hideshima, T.; Brown, M.; Anderson, K. C.; Ghobrial, I. M. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2384134">"Targeting NF-kappaB in Waldenstrom macroglobulinemia"</a>. <i>Blood</i> <b>111</b> (10): 5068–5077. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-09-115170">10.1182/blood-2007-09-115170</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2384134">2384134</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18334673">18334673</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Targeting+NF-kappaB+in+Waldenstrom+macroglobulinemia&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Azab%2C+A.&amp;rft.au=Azab%2C+F.&amp;rft.au=Brown%2C+M.&amp;rft.au=Burwick%2C+N.&amp;rft.au=Carrasco%2C+D.+R.&amp;rft.au=Eeckhoute%2C+J.&amp;rft.au=Farag%2C+M.&amp;rft.aufirst=X.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Hatjiharissi%2C+E.&amp;rft.au=Hideshima%2C+T.&amp;rft.au=Hunter%2C+Z.&amp;rft.au=Jia%2C+X.&amp;rft.aulast=Leleu&amp;rft.au=Leleu%2C+X.&amp;rft.au=Melhem%2C+M.+R.&amp;rft.au=Moreau%2C+A.&amp;rft.au=Ngo%2C+H.&amp;rft.au=Roccaro%2C+A.&amp;rft.au=Runnels%2C+J.&amp;rft.au=Sacco%2C+A.&amp;rft.au=Treon%2C+S.+P.&amp;rft.au=Witzig%2C+T.+E.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2384134&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-09-115170&amp;rft_id=info%3Apmc%2F2384134&amp;rft_id=info%3Apmid%2F18334673&amp;rft.issue=10&amp;rft.jtitle=Blood&amp;rft.pages=5068-5077&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18334673&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Braggio, E.; Keats, J.; Leleu, X.; Van Wier, S.; Jimenez-Zepeda, V.; Valdez, R.; Schop, R.; Price-Troska, T.; Henderson, K.; Sacco, A.; Azab, F.; Greipp, P.; Gertz, M.; Hayman, S.; Rajkumar, S. V.; Carpten, J.; Chesi, M.; Barrett, M.; Stewart, A. K.; Dogan, A.; Bergsagel, P. L.; Ghobrial, I. M.; Fonseca, R. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2782932">"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia"</a>. <i>Cancer Research</i> <b>69</b> (8): 3579–3588. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F0008-5472.CAN-08-3701">10.1158/0008-5472.CAN-08-3701</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2782932">2782932</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19351844">19351844</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Identification+of+copy+number+abnormalities+and+inactivating+mutations+in+two+negative+regulators+of+nuclear+factor-kappaB+signaling+pathways+in+Waldenstrom%27s+macroglobulinemia&amp;rft.au=Azab%2C+F.&amp;rft.au=Barrett%2C+M.&amp;rft.au=Bergsagel%2C+P.+L.&amp;rft.au=Braggio%2C+E.&amp;rft.au=Carpten%2C+J.&amp;rft.au=Chesi%2C+M.&amp;rft.au=Dogan%2C+A.&amp;rft.aufirst=E.&amp;rft.au=Fonseca%2C+R.&amp;rft.au=Gertz%2C+M.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Greipp%2C+P.&amp;rft.au=Hayman%2C+S.&amp;rft.au=Henderson%2C+K.&amp;rft.au=Jimenez-Zepeda%2C+V.&amp;rft.au=Keats%2C+J.&amp;rft.aulast=Braggio&amp;rft.au=Leleu%2C+X.&amp;rft.au=Price-Troska%2C+T.&amp;rft.au=Rajkumar%2C+S.+V.&amp;rft.au=Sacco%2C+A.&amp;rft.au=Schop%2C+R.&amp;rft.au=Stewart%2C+A.+K.&amp;rft.au=Valdez%2C+R.&amp;rft.au=Van+Wier%2C+S.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2782932&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-08-3701&amp;rft_id=info%3Apmc%2F2782932&amp;rft_id=info%3Apmid%2F19351844&amp;rft.issue=8&amp;rft.jtitle=Cancer+Research&amp;rft.pages=3579-3588&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=69" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1158.2F0008-5472.CAN-08-3701&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Gutiérrez, N.; Ocio, E.; De Las Rivas, J.; Maiso, P.; Delgado, M.; Fermiñán, E.; Arcos, M.; Sánchez, M.; Hernández, J.; San Miguel, J. F. (2007). "Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals". <i>Leukemia&#160;: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K</i> <b>21</b> (3): 541–549. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.leu.2404520">10.1038/sj.leu.2404520</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17252022">17252022</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Gene+expression+profiling+of+B+lymphocytes+and+plasma+cells+from+Waldenstr%C3%B6m%27s+macroglobulinemia%3A+comparison+with+expression+patterns+of+the+same+cell+counterparts+from+chronic+lymphocytic+leukemia%2C+multiple+myeloma+and+normal+individuals&amp;rft.au=Arcos%2C+M.&amp;rft.au=De+Las+Rivas%2C+J.&amp;rft.au=Delgado%2C+M.&amp;rft.au=Fermi%C3%B1%C3%A1n%2C+E.&amp;rft.aufirst=N.&amp;rft.au=Guti%C3%A9rrez%2C+N.&amp;rft.au=Hern%C3%A1ndez%2C+J.&amp;rft.aulast=Guti%C3%A9rrez&amp;rft.au=Maiso%2C+P.&amp;rft.au=Ocio%2C+E.&amp;rft.au=San+Miguel%2C+J.+F.&amp;rft.au=S%C3%A1nchez%2C+M.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.leu.2404520&amp;rft_id=info%3Apmid%2F17252022&amp;rft.issue=3&amp;rft.jtitle=Leukemia+%3A+official+journal+of+the+Leukemia+Society+of+America%2C+Leukemia+Research+Fund%2C+U.K&amp;rft.pages=541-549&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1038.2Fsj.leu.2404520&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Burwick, N.; Roccaro, A.; Leleu, X.; Ghobrial, I. (2008). "Targeted therapies in Waldenström macroglobulinemia". <i>Current opinion in investigational drugs (London, England&#160;: 2000)</i> <b>9</b> (6): 631–637. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18516762">18516762</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Targeted+therapies+in+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Burwick%2C+N.&amp;rft.aufirst=N.&amp;rft.au=Ghobrial%2C+I.&amp;rft.aulast=Burwick&amp;rft.au=Leleu%2C+X.&amp;rft.au=Roccaro%2C+A.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F18516762&amp;rft.issue=6&amp;rft.jtitle=Current+opinion+in+investigational+drugs+%28London%2C+England+%3A+2000%29&amp;rft.pages=631-637&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18516762&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Chng, W.; Schop, R.; Price-Troska, T.; Ghobrial, I.; Kay, N.; Jelinek, D.; Gertz, M.; Dispenzieri, A.; Lacy, M.; Kyle, R. A.; Greipp, P. R.; Tschumper, R. C.; Fonseca, R.; Bergsagel, P. L. (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895596">"Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma"</a>. <i>Blood</i> <b>108</b> (8): 2755–2763. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2006-02-005488">10.1182/blood-2006-02-005488</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895596">1895596</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16804116">16804116</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Gene-expression+profiling+of+Waldenstrom+macroglobulinemia+reveals+a+phenotype+more+similar+to+chronic+lymphocytic+leukemia+than+multiple+myeloma&amp;rft.au=Bergsagel%2C+P.+L.&amp;rft.au=Chng%2C+W.&amp;rft.au=Dispenzieri%2C+A.&amp;rft.aufirst=W.&amp;rft.au=Fonseca%2C+R.&amp;rft.au=Gertz%2C+M.&amp;rft.au=Ghobrial%2C+I.&amp;rft.au=Greipp%2C+P.+R.&amp;rft.au=Jelinek%2C+D.&amp;rft.au=Kay%2C+N.&amp;rft.au=Kyle%2C+R.+A.&amp;rft.au=Lacy%2C+M.&amp;rft.aulast=Chng&amp;rft.au=Price-Troska%2C+T.&amp;rft.au=Schop%2C+R.&amp;rft.au=Tschumper%2C+R.+C.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1895596&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2006-02-005488&amp;rft_id=info%3Apmc%2F1895596&amp;rft_id=info%3Apmid%2F16804116&amp;rft.issue=8&amp;rft.jtitle=Blood&amp;rft.pages=2755-2763&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/16804116&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Nichols, G.; Stein, C. (2003). "Modulation of the activity of Bcl-2 in Waldenstrom's macroglobulinemia using antisense oligonucleotides". <i>Seminars in oncology</i> <b>30</b> (2): 297–299. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50045">10.1053/sonc.2003.50045</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720156">12720156</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Modulation+of+the+activity+of+Bcl-2+in+Waldenstrom%27s+macroglobulinemia+using+antisense+oligonucleotides&amp;rft.aufirst=G.&amp;rft.aulast=Nichols&amp;rft.au=Nichols%2C+G.&amp;rft.au=Stein%2C+C.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50045&amp;rft_id=info%3Apmid%2F12720156&amp;rft.issue=2&amp;rft.jtitle=Seminars+in+oncology&amp;rft.pages=297-299&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/12720156&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Ngo, H.; Azab, A.; Farag, M.; Jia, X.; Melhem, M.; Runnels, J.; Roccaro, A.; Azab, F.; Sacco, A.; Leleu, X.; Anderson, K. C.; Ghobrial, I. M. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2990685">"Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia"</a>. <i>Clinical cancer research&#160;: an official journal of the American Association for Cancer Research</i> <b>15</b> (19): 6035–6041. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-09-0718">10.1158/1078-0432.CCR-09-0718</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2990685">2990685</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19755386">19755386</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Src+tyrosine+kinase+regulates+adhesion+and+chemotaxis+in+Waldenstrom+macroglobulinemia&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Azab%2C+A.&amp;rft.au=Azab%2C+F.&amp;rft.au=Farag%2C+M.&amp;rft.aufirst=H.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Jia%2C+X.&amp;rft.aulast=Ngo&amp;rft.au=Leleu%2C+X.&amp;rft.au=Melhem%2C+M.&amp;rft.au=Ngo%2C+H.&amp;rft.au=Roccaro%2C+A.&amp;rft.au=Runnels%2C+J.&amp;rft.au=Sacco%2C+A.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2990685&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-09-0718&amp;rft_id=info%3Apmc%2F2990685&amp;rft_id=info%3Apmid%2F19755386&amp;rft.issue=19&amp;rft.jtitle=Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research&amp;rft.pages=6035-6041&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19755386&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Vacca, A.; Dammacco, F. (2009). "MicroRNAs to know in Waldenstrom macroglobulinemia". <i>Blood</i> <b>113</b> (18): 4133–4134. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2009-01-199828">10.1182/blood-2009-01-199828</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19406998">19406998</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=MicroRNAs+to+know+in+Waldenstrom+macroglobulinemia&amp;rft.au=Dammacco%2C+F.&amp;rft.aufirst=A.&amp;rft.aulast=Vacca&amp;rft.au=Vacca%2C+A.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-01-199828&amp;rft_id=info%3Apmid%2F19406998&amp;rft.issue=18&amp;rft.jtitle=Blood&amp;rft.pages=4133-4134&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=113" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19406998&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Roccaro, A.; Sacco, A.; Chen, C.; Runnels, J.; Leleu, X.; Azab, F.; Azab, A.; Jia, X.; Ngo, H.; Melhem, M. R.; Burwick, N.; Varticovski, L.; Novina, C. D.; Rollins, B. J.; Anderson, K. C.; Ghobrial, I. M. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2943754">"MicroRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia"</a>. <i>Blood</i> <b>113</b> (18): 4391–4402. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-09-178228">10.1182/blood-2008-09-178228</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2943754">2943754</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19074725">19074725</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=MicroRNA+expression+in+the+biology%2C+prognosis%2C+and+therapy+of+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Azab%2C+A.&amp;rft.au=Azab%2C+F.&amp;rft.au=Burwick%2C+N.&amp;rft.au=Chen%2C+C.&amp;rft.aufirst=A.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Jia%2C+X.&amp;rft.aulast=Roccaro&amp;rft.au=Leleu%2C+X.&amp;rft.au=Melhem%2C+M.+R.&amp;rft.au=Ngo%2C+H.&amp;rft.au=Novina%2C+C.+D.&amp;rft.au=Roccaro%2C+A.&amp;rft.au=Rollins%2C+B.+J.&amp;rft.au=Runnels%2C+J.&amp;rft.au=Sacco%2C+A.&amp;rft.au=Varticovski%2C+L.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2943754&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-09-178228&amp;rft_id=info%3Apmc%2F2943754&amp;rft_id=info%3Apmid%2F19074725&amp;rft.issue=18&amp;rft.jtitle=Blood&amp;rft.pages=4391-4402&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=113" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1182.2Fblood-2008-09-178228&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000764">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000764</a></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000490">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000490</a></span></li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0003134">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0003134</a></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000681</a></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000481">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000481</a></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0003686">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0003686</a></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000466">http://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000466</a></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Roccaro, A.; Sacco, A.; Jia, X.; Azab, A.; Maiso, P.; Ngo, H.; Azab, F.; Runnels, J.; Quang, P.; Ghobrial, I. M. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2938840">"microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia"</a>. <i>Blood</i> <b>116</b> (9): 1506–1514. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2010-01-265686">10.1182/blood-2010-01-265686</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2938840">2938840</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20519629">20519629</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=microRNA-dependent+modulation+of+histone+acetylation+in+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Azab%2C+A.&amp;rft.au=Azab%2C+F.&amp;rft.aufirst=A.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.au=Jia%2C+X.&amp;rft.aulast=Roccaro&amp;rft.au=Maiso%2C+P.&amp;rft.au=Ngo%2C+H.&amp;rft.au=Quang%2C+P.&amp;rft.au=Roccaro%2C+A.&amp;rft.au=Runnels%2C+J.&amp;rft.au=Sacco%2C+A.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2938840&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2010-01-265686&amp;rft_id=info%3Apmc%2F2938840&amp;rft_id=info%3Apmid%2F20519629&amp;rft.issue=9&amp;rft.jtitle=Blood&amp;rft.pages=1506-1514&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20519629&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Treon, S.; Kelliher, A.; Keele, B.; Frankel, S.; Emmanouilides, C.; Kimby, E.; Schlossman, R.; Mitsiades, N.; Mitsiades, C.; Preffer, F.; Anderson, K. C. (2003). "Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations". <i>Seminars in oncology</i> <b>30</b> (2): 248–252. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50047">10.1053/sonc.2003.50047</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720146">12720146</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Expression+of+serotherapy+target+antigens+in+Waldenstrom%27s+macroglobulinemia%3A+therapeutic+applications+and+considerations&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Emmanouilides%2C+C.&amp;rft.aufirst=S.&amp;rft.au=Frankel%2C+S.&amp;rft.au=Keele%2C+B.&amp;rft.au=Kelliher%2C+A.&amp;rft.au=Kimby%2C+E.&amp;rft.aulast=Treon&amp;rft.au=Mitsiades%2C+C.&amp;rft.au=Mitsiades%2C+N.&amp;rft.au=Preffer%2C+F.&amp;rft.au=Schlossman%2C+R.&amp;rft.au=Treon%2C+S.&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50047&amp;rft_id=info%3Apmid%2F12720146&amp;rft.issue=2&amp;rft.jtitle=Seminars+in+oncology&amp;rft.pages=248-252&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1053.2Fsonc.2003.50047&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-Owen-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Owen_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Owen RG, Barrans SL, Richards SJ, O'Connor SJ, Child JA, Parapia LA, Morgan GJ, Jack AS; Richards; O'Connor; Morgan; Owen; Parapia; Jack (2001). "Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors". <i>Am J Clin Pathol</i> <b>116</b> (3): 420–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1309%2F4LCN-JMPG-5U71-UWQB">10.1309/4LCN-JMPG-5U71-UWQB</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11554171">11554171</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Waldenstrom+macroglobulinemia.+Development+of+diagnostic+criteria+and+identification+of+prognostic+factors&amp;rft.au=Jack&amp;rft.aulast=Owen+RG%2C+Barrans+SL%2C+Richards+SJ%2C+O%27Connor+SJ%2C+Child+JA%2C+Parapia+LA%2C+Morgan+GJ%2C+Jack+AS&amp;rft.au=Morgan&amp;rft.au=O%27Connor&amp;rft.au=Owen&amp;rft.au=Owen+RG%2C+Barrans+SL%2C+Richards+SJ%2C+O%27Connor+SJ%2C+Child+JA%2C+Parapia+LA%2C+Morgan+GJ%2C+Jack+AS&amp;rft.au=Parapia&amp;rft.au=Richards&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1309%2F4LCN-JMPG-5U71-UWQB&amp;rft_id=info%3Apmid%2F11554171&amp;rft.issue=3&amp;rft.jtitle=Am+J+Clin+Pathol&amp;rft.pages=420-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SanMiguel-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-SanMiguel_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">San Miguel JF, Vidriales MB, Ocio E, Mateo G, Sanchez-Guijo F, Sanchez ML, Escribano L, Barez A, Moro MJ, Hernandez J, Aguilera C, Cuello R, Garcia-Frade J, Lopez R, Portero J, Orfao A (2003). "Immunophenotypic analysis of Waldenstrom's macroglobulinemia". <i>Semin Oncol</i> <b>30</b> (2): 187–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50074">10.1053/sonc.2003.50074</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720134">12720134</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Immunophenotypic+analysis+of+Waldenstrom%27s+macroglobulinemia&amp;rft.aulast=San+Miguel+JF%2C+Vidriales+MB%2C+Ocio+E%2C+Mateo+G%2C+Sanchez-Guijo+F%2C+Sanchez+ML%2C+Escribano+L%2C+Barez+A%2C+Moro+MJ%2C+Hernandez+J%2C+Aguilera+C%2C+Cuello+R%2C+Garcia-Frade+J%2C+Lopez+R%2C+Portero+J%2C+Orfao+A&amp;rft.au=San+Miguel+JF%2C+Vidriales+MB%2C+Ocio+E%2C+Mateo+G%2C+Sanchez-Guijo+F%2C+Sanchez+ML%2C+Escribano+L%2C+Barez+A%2C+Moro+MJ%2C+Hernandez+J%2C+Aguilera+C%2C+Cuello+R%2C+Garcia-Frade+J%2C+Lopez+R%2C+Portero+J%2C+Orfao+A&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50074&amp;rft_id=info%3Apmid%2F12720134&amp;rft.issue=2&amp;rft.jtitle=Semin+Oncol&amp;rft.pages=187-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ghobrial-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ghobrial_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ghobrial IM, Witzig TE (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133652">"Waldenstrom macroglobulinemia"</a>. <i>Curr Treat Options Oncol</i> <b>5</b> (3): 239–47. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11864-004-0015-5">10.1007/s11864-004-0015-5</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133652">3133652</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15115652">15115652</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Waldenstrom+macroglobulinemia&amp;rft.au=Ghobrial+IM%2C+Witzig+TE&amp;rft.aulast=Ghobrial+IM%2C+Witzig+TE&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3133652&amp;rft_id=info%3Adoi%2F10.1007%2Fs11864-004-0015-5&amp;rft_id=info%3Apmc%2F3133652&amp;rft_id=info%3Apmid%2F15115652&amp;rft.issue=3&amp;rft.jtitle=Curr+Treat+Options+Oncol&amp;rft.pages=239-47&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dimopoulos-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dimopoulos_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005). "Diagnosis and management of Waldenstrom's macroglobulinemia". <i>J Clin Oncol</i> <b>23</b> (7): 1564–77. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2005.03.144">10.1200/JCO.2005.03.144</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15735132">15735132</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Diagnosis+and+management+of+Waldenstrom%27s+macroglobulinemia&amp;rft.au=Dimopoulos+MA%2C+Kyle+RA%2C+Anagnostopoulos+A%2C+Treon+SP&amp;rft.aulast=Dimopoulos+MA%2C+Kyle+RA%2C+Anagnostopoulos+A%2C+Treon+SP&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2005.03.144&amp;rft_id=info%3Apmid%2F15735132&amp;rft.issue=7&amp;rft.jtitle=J+Clin+Oncol&amp;rft.pages=1564-77&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.expertconsultbook.com/expertconsult/op/book.do?method=display&amp;type=bookPage&amp;decorator=none&amp;eid=4-u1.0-B978-0-443-06715-0..50090-X--cesec8&amp;isbn=978-0-443-06715-0">Morbidity Mediated By The Effects Of IgM</a> From Chapter 88 - Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma. <span class="citation book">Hoffman, Ronald (2009). <i>Hematology&#160;: basic principles and practic</i>. Philadelphia, PA: Churchill Livingstone/Elsevier. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-443-06715-0" title="Special:BookSources/978-0-443-06715-0">978-0-443-06715-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.aufirst=Ronald&amp;rft.au=Hoffman%2C+Ronald&amp;rft.aulast=Hoffman&amp;rft.btitle=Hematology+%3A+basic+principles+and+practic&amp;rft.date=2009&amp;rft.genre=book&amp;rft.isbn=978-0-443-06715-0&amp;rft.place=Philadelphia%2C+PA&amp;rft.pub=Churchill+Livingstone%2FElsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-workup-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-workup_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-workup_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Ponce, D. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/207097-workup">Waldenstrom Hypergammaglobulinemia Workup</a>. Medscape. Retrieved on: 2011-08-14.</span></li>
<li id="cite_note-NCIfacts-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-NCIfacts_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NCIfacts_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">National Cancer Institute. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/factsheet/Sites-Types/WM">Waldenström Macroglobulinemia: Questions and Answers</a>. Retrieved on: 2011-08-14.</span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text">Criteria for diagnosis of WM- IMWG 2009 guidelines</span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://emedicine.medscape.com/article/207097-overview">http://emedicine.medscape.com/article/207097-overview</a></span></li>
<li id="cite_note-Johansson-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Johansson_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Johansson B, Waldenstrom J, Hasselblom S, Mitelman F (1995). "Waldenstrom's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21)". <i>Leukemia</i> <b>9</b> (7): 1136–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7630185">7630185</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Waldenstrom%27s+macroglobulinemia+with+the+AML%2FMDS-associated+t%281%3B3%29%28p36%3Bq21%29&amp;rft.au=Johansson+B%2C+Waldenstrom+J%2C+Hasselblom+S%2C+Mitelman+F&amp;rft.aulast=Johansson+B%2C+Waldenstrom+J%2C+Hasselblom+S%2C+Mitelman+F&amp;rft.date=1995&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7630185&amp;rft.issue=7&amp;rft.jtitle=Leukemia&amp;rft.pages=1136-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text">Morel P, Duhamel A, Gobbi P, Dimopoulos M, Dhodapkar M, McCoy J, et al. International Prognostic Scoring System for Waldenström’s Macroglobulinemia. XIth International Myeloma Workshop &amp; IVth International Workshop on Waldenstrom's Macroglobulinemia 25 30 June 2007 Kos Island, Greece. <i>Haematologica</i> 2007;92(6 suppl 2):1-229.</span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Kastritis, E.; Kyrtsonis, M.; Hadjiharissi, E.; Symeonidis, A.; Michalis, E.; Repoussis, P.; Tsatalas, C.; Michael, M.; Sioni, A.; Kartasis, Z.; Stefanoudaki, E.; Voulgarelis, M.; Delimpasi, S.; Gavriatopoulou, M.; Koulieris, E.; Gika, D.; Zomas, A.; Roussou, P.; Anagnostopoulos, N.; Economopoulos, T.; Terpos, E.; Zervas, K.; Dimopoulos, M. A.; Greek Myeloma Study, G. (2010). "Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)". <i>Leukemia research</i> <b>34</b> (10): 1340–1343. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.leukres.2010.04.005">10.1016/j.leukres.2010.04.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20447689">20447689</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Validation+of+the+International+Prognostic+Scoring+System+%28IPSS%29+for+Waldenstrom%27s+macroglobulinemia+%28WM%29+and+the+importance+of+serum+lactate+dehydrogenase+%28LDH%29&amp;rft.au=Anagnostopoulos%2C+N.&amp;rft.au=Delimpasi%2C+S.&amp;rft.au=Dimopoulos%2C+M.+A.&amp;rft.au=Economopoulos%2C+T.&amp;rft.aufirst=E.&amp;rft.au=Gavriatopoulou%2C+M.&amp;rft.au=Gika%2C+D.&amp;rft.au=Greek+Myeloma+Study%2C+G.&amp;rft.au=Hadjiharissi%2C+E.&amp;rft.au=Kartasis%2C+Z.&amp;rft.au=Kastritis%2C+E.&amp;rft.au=Koulieris%2C+E.&amp;rft.au=Kyrtsonis%2C+M.&amp;rft.aulast=Kastritis&amp;rft.au=Michael%2C+M.&amp;rft.au=Michalis%2C+E.&amp;rft.au=Repoussis%2C+P.&amp;rft.au=Roussou%2C+P.&amp;rft.au=Sioni%2C+A.&amp;rft.au=Stefanoudaki%2C+E.&amp;rft.au=Symeonidis%2C+A.&amp;rft.au=Terpos%2C+E.&amp;rft.au=Tsatalas%2C+C.&amp;rft.au=Voulgarelis%2C+M.&amp;rft.au=Zervas%2C+K.&amp;rft.au=Zomas%2C+A.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.leukres.2010.04.005&amp;rft_id=info%3Apmid%2F20447689&amp;rft.issue=10&amp;rft.jtitle=Leukemia+research&amp;rft.pages=1340-1343&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20447689&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-PMID_18641029-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMID_18641029_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMID_18641029_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dimopoulos, M.; Kastritis, E.; Delimpassi, S.; Zomas, A.; Kyrtsonis, M.; Zervas, K. (2008). "The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens". <i>Haematologica</i> <b>93</b> (9): 1420–1422. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3324%2Fhaematol.12846">10.3324/haematol.12846</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18641029">18641029</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=The+International+Prognostic+Scoring+System+for+Waldenstrom%27s+macroglobulinemia+is+applicable+in+patients+treated+with+rituximab-based+regimens&amp;rft.au=Delimpassi%2C+S.&amp;rft.au=Dimopoulos%2C+M.&amp;rft.aufirst=M.&amp;rft.au=Kastritis%2C+E.&amp;rft.au=Kyrtsonis%2C+M.&amp;rft.aulast=Dimopoulos&amp;rft.au=Zervas%2C+K.&amp;rft.au=Zomas%2C+A.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3324%2Fhaematol.12846&amp;rft_id=info%3Apmid%2F18641029&amp;rft.issue=9&amp;rft.jtitle=Haematologica&amp;rft.pages=1420-1422&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=93" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18641029&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">Hivert, B.; Tamburini, J.; Vekhoff, A.; Tournilhac, O.; Leblond, V.; Morel, P. (2011-03-10). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3084930">"Prognostic value of the International Scoring System and response in patients with advanced Waldenström macroglobulinemia"</a>. <i><a href="/wiki/Haematologica" title="Haematologica">Haematologica</a></i> <b>96</b> (5): 785–788. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3324%2Fhaematol.2010.029140">10.3324/haematol.2010.029140</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3084930">3084930</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21393333">21393333</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Prognostic+value+of+the+International+Scoring+System+and+response+in+patients+with+advanced+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.aufirst=B.&amp;rft.au=Hivert%2C+B.&amp;rft.aulast=Hivert&amp;rft.au=Leblond%2C+V.&amp;rft.au=Morel%2C+P.&amp;rft.au=Tamburini%2C+J.&amp;rft.au=Tournilhac%2C+O.&amp;rft.au=Vekhoff%2C+A.&amp;rft.date=2011-03-10&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3084930&amp;rft_id=info%3Adoi%2F10.3324%2Fhaematol.2010.029140&amp;rft_id=info%3Apmc%2F3084930&amp;rft_id=info%3Apmid%2F21393333&amp;rft.issue=5&amp;rft.jtitle=Haematologica&amp;rft.pages=785-788&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=96" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/21393333&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">Dhodapkar, M.; Hoering, A.; Gertz, M.; Rivkin, S.; Szymonifka, J.; Crowley, J.; Barlogie, B. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2630265">"Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003"</a>. <i>Blood</i> <b>113</b> (4): 793–796. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-07-172080">10.1182/blood-2008-07-172080</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2630265">2630265</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18931340">18931340</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Long-term+survival+in+Waldenstrom+macroglobulinemia%3A+10-year+follow-up+of+Southwest+Oncology+Group-directed+intergroup+trial+S9003&amp;rft.au=Barlogie%2C+B.&amp;rft.au=Crowley%2C+J.&amp;rft.au=Dhodapkar%2C+M.&amp;rft.aufirst=M.&amp;rft.au=Gertz%2C+M.&amp;rft.au=Hoering%2C+A.&amp;rft.aulast=Dhodapkar&amp;rft.au=Rivkin%2C+S.&amp;rft.au=Szymonifka%2C+J.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2630265&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-07-172080&amp;rft_id=info%3Apmc%2F2630265&amp;rft_id=info%3Apmid%2F18931340&amp;rft.issue=4&amp;rft.jtitle=Blood&amp;rft.pages=793-796&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=113" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18931340&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation journal">Leleu, X.; Gay, J.; Roccaro, A.; Moreau, A.; Poulain, S.; Dulery, R.; Champs, B.; Robu, D.; Ghobrial, I. (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133624">"Update on therapeutic options in Waldenström macroglobulinemia"</a>. <i>European journal of haematology</i> <b>82</b> (1): 1–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1600-0609.2008.01171.x">10.1111/j.1600-0609.2008.01171.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3133624">3133624</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19087134">19087134</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Update+on+therapeutic+options+in+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Champs%2C+B.&amp;rft.au=Dulery%2C+R.&amp;rft.aufirst=X.&amp;rft.au=Gay%2C+J.&amp;rft.au=Ghobrial%2C+I.&amp;rft.aulast=Leleu&amp;rft.au=Leleu%2C+X.&amp;rft.au=Moreau%2C+A.&amp;rft.au=Poulain%2C+S.&amp;rft.au=Robu%2C+D.&amp;rft.au=Roccaro%2C+A.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3133624&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0609.2008.01171.x&amp;rft_id=info%3Apmc%2F3133624&amp;rft_id=info%3Apmid%2F19087134&amp;rft.issue=1&amp;rft.jtitle=European+journal+of+haematology&amp;rft.pages=1-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=82" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19087134&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation web">Goodin, Tara (29 January 2015). <a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm432123.htm?sf35886412=1">"FDA expands approved use of Imbruvica for rare form of non-Hodgkin lymphoma"</a>. FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">29 January</span> 2015</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.aufirst=Tara&amp;rft.au=Goodin%2C+Tara&amp;rft.aulast=Goodin&amp;rft.btitle=FDA+expands+approved+use+of+Imbruvica+for+rare+form+of+non-Hodgkin+lymphoma&amp;rft.date=29+January+2015&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm432123.htm%3Fsf35886412%3D1&amp;rft.pub=FDA&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal">Treon, S. P. (2009). "How I treat Waldenström macroglobulinemia". <i>Blood</i> <b>114</b> (12): 2375–2385. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2009-05-174359">10.1182/blood-2009-05-174359</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19617573">19617573</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=How+I+treat+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.aufirst=S.+P.&amp;rft.aulast=Treon&amp;rft.au=Treon%2C+S.+P.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2009-05-174359&amp;rft_id=info%3Apmid%2F19617573&amp;rft.issue=12&amp;rft.jtitle=Blood&amp;rft.pages=2375-2385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=114" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/19617573&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><span class="citation journal">Ansell, S. M.; Kyle, R. A.; Reeder, C. B.; Fonseca, R.; Mikhael, J. R.; Morice, W. G.; Bergsagel, P. L.; Buadi, F. K.; Colgan, J. P.; Dingli, D.; Dispenzieri, A.; Greipp, P. R.; Habermann, T. M.; Hayman, S. R.; Inwards, D. J.; Johnston, P. B.; Kumar, S. K.; Lacy, M. Q.; Lust, J. A.; Markovic, S. N.; Micallef, I. N. M.; Nowakowski, G. S.; Porrata, L. F.; Roy, V.; Russell, S. J.; Short, K. E. D.; Stewart, A. K.; Thompson, C. A.; Witzig, T. E.; Zeldenrust, S. R. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2931618">"Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines"</a>. <i>Mayo Clinic proceedings. Mayo Clinic</i> <b>85</b> (9): 824–833. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4065%2Fmcp.2010.0304">10.4065/mcp.2010.0304</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2931618">2931618</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20702770">20702770</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Diagnosis+and+Management+of+Waldenstr%C3%B6m+Macroglobulinemia%3A+Mayo+Stratification+of+Macroglobulinemia+and+Risk-Adapted+Therapy+%28mSMART%29+Guidelines&amp;rft.au=Ansell%2C+S.+M.&amp;rft.au=Bergsagel%2C+P.+L.&amp;rft.au=Buadi%2C+F.+K.&amp;rft.au=Colgan%2C+J.+P.&amp;rft.au=Dingli%2C+D.&amp;rft.au=Dispenzieri%2C+A.&amp;rft.aufirst=S.+M.&amp;rft.au=Fonseca%2C+R.&amp;rft.au=Greipp%2C+P.+R.&amp;rft.au=Habermann%2C+T.+M.&amp;rft.au=Hayman%2C+S.+R.&amp;rft.au=Inwards%2C+D.+J.&amp;rft.au=Johnston%2C+P.+B.&amp;rft.au=Kumar%2C+S.+K.&amp;rft.au=Kyle%2C+R.+A.&amp;rft.au=Lacy%2C+M.+Q.&amp;rft.aulast=Ansell&amp;rft.au=Lust%2C+J.+A.&amp;rft.au=Markovic%2C+S.+N.&amp;rft.au=Micallef%2C+I.+N.+M.&amp;rft.au=Mikhael%2C+J.+R.&amp;rft.au=Morice%2C+W.+G.&amp;rft.au=Nowakowski%2C+G.+S.&amp;rft.au=Porrata%2C+L.+F.&amp;rft.au=Reeder%2C+C.+B.&amp;rft.au=Roy%2C+V.&amp;rft.au=Russell%2C+S.+J.&amp;rft.au=Short%2C+K.+E.+D.&amp;rft.au=Stewart%2C+A.+K.&amp;rft.au=Thompson%2C+C.+A.&amp;rft.au=Witzig%2C+T.+E.&amp;rft.au=Zeldenrust%2C+S.+R.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2931618&amp;rft_id=info%3Adoi%2F10.4065%2Fmcp.2010.0304&amp;rft_id=info%3Apmc%2F2931618&amp;rft_id=info%3Apmid%2F20702770&amp;rft.issue=9&amp;rft.jtitle=Mayo+Clinic+proceedings.+Mayo+Clinic&amp;rft.pages=824-833&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20702770&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Varettoni, M.; Tedeschi, A.; Arcaini, L.; Pascutto, C.; Vismara, E.; Orlandi, E.; Ricci, F.; Corso, A.; Greco, A.; Mangiacavalli, S.; Lazzarino, M.; Morra, E. (2011). "Risk of second cancers in Waldenstrom macroglobulinemia". <i>Annals of Oncology</i> <b>23</b> (2): 411–415. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fannonc%2Fmdr119">10.1093/annonc/mdr119</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21525403">21525403</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Risk+of+second+cancers+in+Waldenstrom+macroglobulinemia&amp;rft.au=Arcaini%2C+L.&amp;rft.au=Corso%2C+A.&amp;rft.aufirst=M.&amp;rft.au=Greco%2C+A.&amp;rft.aulast=Varettoni&amp;rft.au=Lazzarino%2C+M.&amp;rft.au=Mangiacavalli%2C+S.&amp;rft.au=Morra%2C+E.&amp;rft.au=Orlandi%2C+E.&amp;rft.au=Pascutto%2C+C.&amp;rft.au=Ricci%2C+F.&amp;rft.au=Tedeschi%2C+A.&amp;rft.au=Varettoni%2C+M.&amp;rft.au=Vismara%2C+E.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdr119&amp;rft_id=info%3Apmid%2F21525403&amp;rft.issue=2&amp;rft.jtitle=Annals+of+Oncology&amp;rft.pages=411-415&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/21525403&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://emedicine.medscape.com/article/207097-treatment">http://emedicine.medscape.com/article/207097-treatment</a></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation journal">Waldenström J (1991). "To treat or not to treat, this is the real question". <i>Leuk Res</i> <b>15</b> (6): 407–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0145-2126%2891%2990049-Y">10.1016/0145-2126(91)90049-Y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1907339">1907339</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=To+treat+or+not+to+treat%2C+this+is+the+real+question&amp;rft.aulast=Waldenstr%C3%B6m+J&amp;rft.au=Waldenstr%C3%B6m+J&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0145-2126%2891%2990049-Y&amp;rft_id=info%3Apmid%2F1907339&amp;rft.issue=6&amp;rft.jtitle=Leuk+Res&amp;rft.pages=407-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Baehring, J.; Hochberg, E.; Raje, N.; Ulrickson, M.; Hochberg, F. (2008). "Neurological manifestations of Waldenström macroglobulinemia". <i>Nature clinical practice. Neurology</i> <b>4</b> (10): 547–556. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fncpneuro0917">10.1038/ncpneuro0917</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18813229">18813229</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Neurological+manifestations+of+Waldenstr%C3%B6m+macroglobulinemia&amp;rft.au=Baehring%2C+J.&amp;rft.aufirst=J.&amp;rft.au=Hochberg%2C+E.&amp;rft.au=Hochberg%2C+F.&amp;rft.aulast=Baehring&amp;rft.au=Raje%2C+N.&amp;rft.au=Ulrickson%2C+M.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fncpneuro0917&amp;rft_id=info%3Apmid%2F18813229&amp;rft.issue=10&amp;rft.jtitle=Nature+clinical+practice.+Neurology&amp;rft.pages=547-556&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18813229&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-Kyel2003-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kyel2003_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kyle RA, Treon SP, Alexanian R, Barlogie B, Bjorkholm M, Dhodapkar M, Lister TA, Merlini G, Morel P, Stone M, Branagan AR, Leblond V (2003). "Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia". <i>Semin Oncol</i> <b>30</b> (2): 116–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50038">10.1053/sonc.2003.50038</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720119">12720119</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Prognostic+markers+and+criteria+to+initiate+therapy+in+Waldenstrom%27s+macroglobulinemia%3A+consensus+panel+recommendations+from+the+Second+International+Workshop+on+Waldenstrom%27s+Macroglobulinemia&amp;rft.au=Kyle+RA%2C+Treon+SP%2C+Alexanian+R%2C+Barlogie+B%2C+Bjorkholm+M%2C+Dhodapkar+M%2C+Lister+TA%2C+Merlini+G%2C+Morel+P%2C+Stone+M%2C+Branagan+AR%2C+Leblond+V&amp;rft.aulast=Kyle+RA%2C+Treon+SP%2C+Alexanian+R%2C+Barlogie+B%2C+Bjorkholm+M%2C+Dhodapkar+M%2C+Lister+TA%2C+Merlini+G%2C+Morel+P%2C+Stone+M%2C+Branagan+AR%2C+Leblond+V&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50038&amp;rft_id=info%3Apmid%2F12720119&amp;rft.issue=2&amp;rft.jtitle=Semin+Oncol&amp;rft.pages=116-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation journal">Treon, S.; Soumerai, J.; Branagan, A.; Hunter, Z.; Patterson, C.; Ioakimidis, L.; Briccetti, F.; Pasmantier, M.; Zimbler, H.; Cooper, R. B.; Moore, M.; Hill j, J.; Rauch, A.; Garbo, L.; Chu, L.; Chua, C.; Nantel, S. H.; Lovett, D. R.; Boedeker, H.; Sonneborn, H.; Howard, J.; Musto, P.; Ciccarelli, B. T.; Hatjiharissi, E.; Anderson, K. C. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2597120">"Thalidomide and rituximab in Waldenstrom macroglobulinemia"</a>. <i>Blood</i> <b>112</b> (12): 4452–4457. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2008-04-150854">10.1182/blood-2008-04-150854</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2597120">2597120</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18713945">18713945</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Thalidomide+and+rituximab+in+Waldenstrom+macroglobulinemia&amp;rft.au=Anderson%2C+K.+C.&amp;rft.au=Boedeker%2C+H.&amp;rft.au=Branagan%2C+A.&amp;rft.au=Briccetti%2C+F.&amp;rft.au=Chu%2C+L.&amp;rft.au=Chua%2C+C.&amp;rft.au=Ciccarelli%2C+B.+T.&amp;rft.au=Cooper%2C+R.+B.&amp;rft.aufirst=S.&amp;rft.au=Garbo%2C+L.&amp;rft.au=Hatjiharissi%2C+E.&amp;rft.au=Hill+j%2C+J.&amp;rft.au=Howard%2C+J.&amp;rft.au=Hunter%2C+Z.&amp;rft.au=Ioakimidis%2C+L.&amp;rft.aulast=Treon&amp;rft.au=Lovett%2C+D.+R.&amp;rft.au=Moore%2C+M.&amp;rft.au=Musto%2C+P.&amp;rft.au=Nantel%2C+S.+H.&amp;rft.au=Pasmantier%2C+M.&amp;rft.au=Patterson%2C+C.&amp;rft.au=Rauch%2C+A.&amp;rft.au=Sonneborn%2C+H.&amp;rft.au=Soumerai%2C+J.&amp;rft.au=Treon%2C+S.&amp;rft.au=Zimbler%2C+H.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2597120&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2008-04-150854&amp;rft_id=info%3Apmc%2F2597120&amp;rft_id=info%3Apmid%2F18713945&amp;rft.issue=12&amp;rft.jtitle=Blood&amp;rft.pages=4452-4457&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=112" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/18713945&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-Gertz-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gertz_65-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gertz MA (2005). "Waldenstrom macroglobulinemia: a review of therapy". <i>Am J Hematol</i> <b>79</b> (2): 147–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fajh.20363">10.1002/ajh.20363</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15929102">15929102</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Waldenstrom+macroglobulinemia%3A+a+review+of+therapy&amp;rft.au=Gertz+MA&amp;rft.aulast=Gertz+MA&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fajh.20363&amp;rft_id=info%3Apmid%2F15929102&amp;rft.issue=2&amp;rft.jtitle=Am+J+Hematol&amp;rft.pages=147-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=79" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Yang-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-Yang_66-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yang L, Wen B, Li H, Yang M, Jin Y, Yang S, Tao J (1999). "Autologous peripheral blood stem cell transplantation for Waldenstrom's macroglobulinemia". <i>Bone Marrow Transplant</i> <b>24</b> (8): 929–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bmt.1701992">10.1038/sj.bmt.1701992</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10516708">10516708</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Autologous+peripheral+blood+stem+cell+transplantation+for+Waldenstrom%27s+macroglobulinemia&amp;rft.aulast=Yang+L%2C+Wen+B%2C+Li+H%2C+Yang+M%2C+Jin+Y%2C+Yang+S%2C+Tao+J&amp;rft.au=Yang+L%2C+Wen+B%2C+Li+H%2C+Yang+M%2C+Jin+Y%2C+Yang+S%2C+Tao+J&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1701992&amp;rft_id=info%3Apmid%2F10516708&amp;rft.issue=8&amp;rft.jtitle=Bone+Marrow+Transplant&amp;rft.pages=929-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Martino-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-Martino_67-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Martino R, Shah A, Romero P, Brunet S, Sierra J, Domingo-Albos A, Fruchtman S, Isola L (1999). "Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia". <i>Bone Marrow Transplant</i> <b>23</b> (7): 747–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bmt.1701633">10.1038/sj.bmt.1701633</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10218857">10218857</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Allogeneic+bone+marrow+transplantation+for+advanced+Waldenstrom%27s+macroglobulinemia&amp;rft.aulast=Martino+R%2C+Shah+A%2C+Romero+P%2C+Brunet+S%2C+Sierra+J%2C+Domingo-Albos+A%2C+Fruchtman+S%2C+Isola+L&amp;rft.au=Martino+R%2C+Shah+A%2C+Romero+P%2C+Brunet+S%2C+Sierra+J%2C+Domingo-Albos+A%2C+Fruchtman+S%2C+Isola+L&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1701633&amp;rft_id=info%3Apmid%2F10218857&amp;rft.issue=7&amp;rft.jtitle=Bone+Marrow+Transplant&amp;rft.pages=747-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Anagnostopoulos-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-Anagnostopoulos_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Anagnostopoulos A, Dimopoulos MA, Aleman A, Weber D, Alexanian R, Champlin R, Giralt S (2001). "High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia". <i>Bone Marrow Transplant</i> <b>27</b> (10): 1027–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.bmt.1703041">10.1038/sj.bmt.1703041</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11438816">11438816</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=High-dose+chemotherapy+followed+by+stem+cell+transplantation+in+patients+with+resistant+Waldenstrom%27s+macroglobulinemia&amp;rft.au=Anagnostopoulos+A%2C+Dimopoulos+MA%2C+Aleman+A%2C+Weber+D%2C+Alexanian+R%2C+Champlin+R%2C+Giralt+S&amp;rft.aulast=Anagnostopoulos+A%2C+Dimopoulos+MA%2C+Aleman+A%2C+Weber+D%2C+Alexanian+R%2C+Champlin+R%2C+Giralt+S&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.bmt.1703041&amp;rft_id=info%3Apmid%2F11438816&amp;rft.issue=10&amp;rft.jtitle=Bone+Marrow+Transplant&amp;rft.pages=1027-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tournilhac-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tournilhac_69-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tournilhac O, Leblond V, Tabrizi R, Gressin R, Senecal D, Milpied N, Cazin B, Divine M, Dreyfus B, Cahn JY, Pignon B, Desablens B, Perrier JF, Bay JO, Travade P (2003). "Transplantation in Waldenstrom's macroglobulinemia--the French experience". <i>Semin Oncol</i> <b>30</b> (2): 291–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fsonc.2003.50048">10.1053/sonc.2003.50048</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12720155">12720155</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Transplantation+in+Waldenstrom%27s+macroglobulinemia--the+French+experience&amp;rft.aulast=Tournilhac+O%2C+Leblond+V%2C+Tabrizi+R%2C+Gressin+R%2C+Senecal+D%2C+Milpied+N%2C+Cazin+B%2C+Divine+M%2C+Dreyfus+B%2C+Cahn+JY%2C+Pignon+B%2C+Desablens+B%2C+Perrier+JF%2C+Bay+JO%2C+Travade+P&amp;rft.au=Tournilhac+O%2C+Leblond+V%2C+Tabrizi+R%2C+Gressin+R%2C+Senecal+D%2C+Milpied+N%2C+Cazin+B%2C+Divine+M%2C+Dreyfus+B%2C+Cahn+JY%2C+Pignon+B%2C+Desablens+B%2C+Perrier+JF%2C+Bay+JO%2C+Travade+P&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fsonc.2003.50048&amp;rft_id=info%3Apmid%2F12720155&amp;rft.issue=2&amp;rft.jtitle=Semin+Oncol&amp;rft.pages=291-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Kyriakou, C.; Canals, C.; Cornelissen, J. J.; Socie, G.; Willemze, R.; Ifrah, N.; Greinix, H. T.; Blaise, D.; Deconinck, E.; Ferrant, A.; Schattenberg, A.; Harousseau, J. -L.; Sureda, A.; Schmitz, N. (2010). "Allogeneic Stem-Cell Transplantation in Patients with Waldenstrom Macroglobulinemia: Report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation". <i>Journal of clinical oncology&#160;: official journal of the American Society of Clinical Oncology</i> <b>28</b> (33): 4926–4934. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2009.27.3607">10.1200/JCO.2009.27.3607</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20956626">20956626</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Allogeneic+Stem-Cell+Transplantation+in+Patients+with+Waldenstrom+Macroglobulinemia%3A+Report+from+the+Lymphoma+Working+Party+of+the+European+Group+for+Blood+and+Marrow+Transplantation&amp;rft.au=Blaise%2C+D.&amp;rft.au=Canals%2C+C.&amp;rft.au=Cornelissen%2C+J.+J.&amp;rft.au=Deconinck%2C+E.&amp;rft.au=Ferrant%2C+A.&amp;rft.aufirst=C.&amp;rft.au=Greinix%2C+H.+T.&amp;rft.au=Harousseau%2C+J.+-L.&amp;rft.au=Ifrah%2C+N.&amp;rft.au=Kyriakou%2C+C.&amp;rft.aulast=Kyriakou&amp;rft.au=Schattenberg%2C+A.&amp;rft.au=Schmitz%2C+N.&amp;rft.au=Socie%2C+G.&amp;rft.au=Sureda%2C+A.&amp;rft.au=Willemze%2C+R.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.27.3607&amp;rft_id=info%3Apmid%2F20956626&amp;rft.issue=33&amp;rft.jtitle=Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology&amp;rft.pages=4926-4934&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20956626&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><span class="citation journal">Rourke, M.; Anderson, K. C.; Ghobrial, I. M. (2010). "Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients". <i>Leukemia &amp; Lymphoma</i> <b>51</b> (10): 1779. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F10428194.2010.499977">10.3109/10428194.2010.499977</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Review+of+clinical+trials+conducted+in+Waldenstrom+macroglobulinemia+and+recommendations+for+reporting+clinical+trial+responses+in+these+patients&amp;rft.au=Anderson%2C+K.+C.&amp;rft.aufirst=M.&amp;rft.au=Ghobrial%2C+I.+M.&amp;rft.aulast=Rourke&amp;rft.au=Rourke%2C+M.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F10428194.2010.499977&amp;rft.issue=10&amp;rft.jtitle=Leukemia+%26+Lymphoma&amp;rft.pages=1779&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/20795787&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://clinicaltrials.gov/ct2/results?term=Waldenstrom">http://clinicaltrials.gov/ct2/results?term=Waldenstrom</a></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><span class="citation journal">Treon, S. P.; Yang, G.; Hanzis, C.; Ioakimidis, L.; Verselis, S. J.; Fox, E. A.; Xu, L.; Hunter, Z. R.; Tseng, H.; Manning, R. J.; Patterson, C. J.; Sheehy, P.; Turnbull, B. (2011). "Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia". <i>British Journal of Haematology</i> <b>154</b> (2): 223–228. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2141.2011.08726.x">10.1111/j.1365-2141.2011.08726.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21564078">21564078</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Attainment+of+complete%2Fvery+good+partial+response+following+rituximab-based+therapy+is+an+important+determinant+to+progression-free+survival%2C+and+is+impacted+by+polymorphisms+in+FCGR3A+in+Waldenstrom+macroglobulinaemia&amp;rft.aufirst=S.+P.&amp;rft.au=Fox%2C+E.+A.&amp;rft.au=Hanzis%2C+C.&amp;rft.au=Hunter%2C+Z.+R.&amp;rft.au=Ioakimidis%2C+L.&amp;rft.aulast=Treon&amp;rft.au=Manning%2C+R.+J.&amp;rft.au=Patterson%2C+C.+J.&amp;rft.au=Sheehy%2C+P.&amp;rft.au=Treon%2C+S.+P.&amp;rft.au=Tseng%2C+H.&amp;rft.au=Turnbull%2C+B.&amp;rft.au=Verselis%2C+S.+J.&amp;rft.au=Xu%2C+L.&amp;rft.au=Yang%2C+G.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2011.08726.x&amp;rft_id=info%3Apmid%2F21564078&amp;rft.issue=2&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.pages=223-228&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=154" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="plainlinks noprint" style="font-size:smaller"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1111.2Fj.1365-2141.2011.08726.x&amp;action=edit&amp;editintro=Template:Cite_doi/editintro2">edit</a></span></span></li>
<li id="cite_note-isbn0-7817-5007-5-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0-7817-5007-5_74-0">^</a></b></span> <span class="reference-text"><span class="citation book">Turgeon, Mary Louise (2005). <i>Clinical hematology: theory and procedures</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. p.&#160;283. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-5007-5" title="Special:BookSources/0-7817-5007-5">0-7817-5007-5</a>. <q>Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)</q></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.aulast=Turgeon%2C+Mary+Louise&amp;rft.au=Turgeon%2C+Mary+Louise&amp;rft.btitle=Clinical+hematology%3A+theory+and+procedures&amp;rft.date=2005&amp;rft.genre=book&amp;rft.isbn=0-7817-5007-5&amp;rft.pages=283&amp;rft.place=Hagerstown%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid_.3D_24189269-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid_.3D_24189269_75-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wada N (Jan 2014). <a rel="nofollow" class="external text" href="http://www.nature.com/labinvest/journal/v94/n1/full/labinvest2013129a.html">"Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line"</a>. <i>Lab Invest.</i> <b>94</b> (1): 79–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Flabinvest.2013.129">10.1038/labinvest.2013.129</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24189269">24189269</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AWaldenstr%C3%B6m%27s+macroglobulinemia&amp;rft.atitle=Characterization+of+subpopulation+lacking+both+B-cell+and+plasma+cell+markers+in+Waldenstrom+macroglobulinemia+cell+line&amp;rft.aulast=Wada+N&amp;rft.au=Wada+N&amp;rft.date=Jan+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Flabinvest%2Fjournal%2Fv94%2Fn1%2Ffull%2Flabinvest2013129a.html&amp;rft_id=info%3Adoi%2F10.1038%2Flabinvest.2013.129&amp;rft_id=info%3Apmid%2F24189269&amp;rft.issue=1&amp;rft.jtitle=Lab+Invest.&amp;rft.pages=79-88&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=94" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit&amp;section=18" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.wmprogram.com/">The Bing Center for Waldenström's Research</a></li>
<li><a rel="nofollow" class="external text" href="http://www.wmworkshop.org/">The International Workshops on Waldenström's Macroglobulinemia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.wmsummit.org/">The International Patient-Physician Summits on Waldenström's Macroglobulinemia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.wmctg.org/">The Waldenström's Macroglobulinemia Clinical Trials Group</a></li>
<li><a rel="nofollow" class="external text" href="http://www.iwmf.com/">The International Waldenström's Macroglobulinemia Foundation site</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=76">American Cancer Society Detailed Guide: Waldenström's Macroglobulinemia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.lymphomas.org.uk">Lymphoma Association – Specialist UK charity providing free information and support to patients, their families, friends and carers</a></li>
<li><a rel="nofollow" class="external text" href="http://www.wmuk.org.uk/">WMUK- Charitable Point of Contact and Support for Waldenström's Macroglobulinemia in the UK</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymphoid_malignancy" title="Template talk:Lymphoid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology#.289590.E2.80.939999.29_Hematologic_.28Leukemias.2C_Lymphomas_and_related_disorders.29" title="International Classification of Diseases for Oncology">ICD-O 9590–9989</a>, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)<br />
<a href="/wiki/Lymphocyte" title="Lymphocyte">Lymphoid</a>/<a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative</a>, <a href="/wiki/Lymphoma" title="Lymphoma">Lymphomas</a>/<a href="/wiki/Lymphoid_leukemia" title="Lymphoid leukemia">Lymphoid leukemias</a> (9590–9739, 9800–9839)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_B_cell_neoplasms" title="Lymphoma">B cell</a><br />
(<a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/B-cell_leukemia" title="B-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD19" title="CD19">CD19</a>
<ul>
<li><a href="/wiki/CD20" title="CD20">CD20</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_B-cell_lymphoblastic_leukemia" title="Precursor B-cell lymphoblastic leukemia">Precursor B acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a></i> (<a href="/wiki/B-cell_chronic_lymphocytic_leukemia" title="B-cell chronic lymphocytic leukemia">CLL/SLL</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Mantle_zone" title="Mantle zone">mantle zone</a></i> (<a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD22" title="CD22">CD22</a>+</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">Prolymphocytic</a></li>
<li><i><a href="/wiki/CD11c" title="CD11c">CD11c+</a></i> (<a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CD79A" title="CD79A">CD79a</a>+</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Germinal_center" title="Germinal center">germinal center</a>/<a href="/wiki/Follicular_B_cell" title="Follicular B cell">follicular B cell</a></i> (<a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular</a></li>
<li><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's</a></li>
<li><a href="/wiki/GCB_DLBCL" title="GCB DLBCL" class="mw-redirect">GCB DLBCL</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Marginal_zone_B-cell_lymphoma" title="Marginal zone B-cell lymphoma">marginal zone</a>/<a href="/wiki/Marginal-zone_B_cell" title="Marginal-zone B cell" class="mw-redirect">marginal-zone B cell</a></i> (<a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone</a></li>
<li><a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT</a></li>
<li><a href="/wiki/Nodal_marginal_zone_B_cell_lymphoma" title="Nodal marginal zone B cell lymphoma">Nodal marginal zone</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reed-Sternberg_cell" title="Reed-Sternberg cell" class="mw-redirect">RS</a> (<a href="/wiki/CD15" title="CD15">CD15</a>+, <a href="/wiki/CD30" title="CD30">CD30</a>+)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Classic Hodgkin's lymphoma</a> (<a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosis</a>)</li>
<li><i><a href="/wiki/CD20" title="CD20">CD20+</a></i> (<a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a><br />
(<a href="/wiki/CD38" title="CD38">CD38</a>+/<a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a>+)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>see <a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">immunoproliferative immunoglobulin disorders</a></i></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">KSHV</a></i> (<a href="/wiki/Primary_effusion_lymphoma" title="Primary effusion lymphoma">Primary effusion</a>)</li>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">Lymphomatoid granulomatosis</a></li>
<li><a href="/wiki/Post-transplant_lymphoproliferative_disorder" title="Post-transplant lymphoproliferative disorder">Post-transplant lymphoproliferative disorder</a>)</li>
<li><i><a href="/wiki/HIV" title="HIV">HIV</a></i> (<a href="/wiki/AIDS-related_lymphoma" title="AIDS-related lymphoma">AIDS-related lymphoma</a>)</li>
<li><i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> (<a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_B-cell_lymphoma" title="Cutaneous B-cell lymphoma">Cutaneous</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_large_B-cell_lymphoma" title="Diffuse large B-cell lymphoma">Diffuse large B-cell lymphoma</a></li>
<li><a href="/wiki/Intravascular_large_B-cell_lymphoma" title="Intravascular large B-cell lymphoma">Intravascular large B-cell lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_marginal_zone_lymphoma" title="Primary cutaneous marginal zone lymphoma">Primary cutaneous marginal zone lymphoma</a></li>
<li><a href="/wiki/Primary_cutaneous_immunocytoma" title="Primary cutaneous immunocytoma">Primary cutaneous immunocytoma</a></li>
<li><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a></li>
<li><a href="/wiki/Plasmacytosis" title="Plasmacytosis">Plasmacytosis</a></li>
<li><a href="/wiki/Primary_cutaneous_follicular_lymphoma" title="Primary cutaneous follicular lymphoma" class="mw-redirect">Primary cutaneous follicular lymphoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">T/NK</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/T_cell" title="T cell">T cell</a><br />
(<a href="/wiki/T-cell_lymphoma" title="T-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/T-cell_leukemia" title="T-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a>
<ul>
<li><a href="/wiki/CD4" title="CD4">CD4</a></li>
<li><a href="/wiki/CD8" title="CD8">CD8</a>)</li>
</ul>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">By development/<br />
marker</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a>: <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_T-cell_lymphoblastic_leukemia" title="Precursor T-cell lymphoblastic leukemia" class="mw-redirect">Precursor T acute lymphoblastic leukemia/lymphoma</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/Prolymphocyte" title="Prolymphocyte">prolymphocyte</a></i> (<a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">Prolymphocytic</a>)</li>
</ul>
<ul>
<li><i><a href="/wiki/CD30" title="CD30">CD30+</a></i> (<a href="/wiki/Anaplastic_large-cell_lymphoma" title="Anaplastic large-cell lymphoma">Anaplastic large-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_T-cell_lymphoma" title="Cutaneous T-cell lymphoma" class="mw-redirect">Cutaneous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">MF+variants</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>indolent:</i> <a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">Mycosis fungoides</a></li>
<li><a href="/wiki/Pagetoid_reticulosis" title="Pagetoid reticulosis">Pagetoid reticulosis</a></li>
<li><a href="/wiki/Granulomatous_slack_skin" title="Granulomatous slack skin">Granulomatous slack skin</a></li>
</ul>
<p><i>aggressive:</i> <a href="/wiki/S%C3%A9zary_disease" title="Sézary disease">Sézary disease</a></p>
<ul>
<li><a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Non-MF</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>-: <a href="/wiki/Non-mycosis_fungoides_CD30%E2%88%92_cutaneous_large_T-cell_lymphoma" title="Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma">Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma</a></li>
<li><a href="/wiki/Pleomorphic_T-cell_lymphoma" title="Pleomorphic T-cell lymphoma">Pleomorphic T-cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type B</a></li>
</ul>
<ul>
<li><a href="/wiki/CD30" title="CD30">CD30</a>+: <a href="/wiki/CD30%2B_cutaneous_T-cell_lymphoma" title="CD30+ cutaneous T-cell lymphoma">CD30+ cutaneous T-cell lymphoma</a></li>
<li><a href="/wiki/Secondary_cutaneous_CD30%2B_large_cell_lymphoma" title="Secondary cutaneous CD30+ large cell lymphoma" class="mw-redirect">Secondary cutaneous CD30+ large cell lymphoma</a></li>
<li><a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis type A</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Peripheral_T-cell_lymphoma" title="Peripheral T-cell lymphoma">peripheral</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hepatosplenic_T-cell_lymphoma" title="Hepatosplenic T-cell lymphoma">Hepatosplenic</a></li>
<li><a href="/wiki/Angioimmunoblastic_T-cell_lymphoma" title="Angioimmunoblastic T-cell lymphoma">Angioimmunoblastic</a></li>
<li><a href="/wiki/Enteropathy-associated_T-cell_lymphoma" title="Enteropathy-associated T-cell lymphoma">Enteropathy-associated T-cell lymphoma</a></li>
<li><a href="/wiki/Peripheral_T-cell_lymphoma-Not-Otherwise-Specified" title="Peripheral T-cell lymphoma-Not-Otherwise-Specified" class="mw-redirect">Peripheral T-cell lymphoma-Not-Otherwise-Specified</a> (<a href="/wiki/Lennert_lymphoma" title="Lennert lymphoma">Lennert lymphoma</a>)</li>
<li><a href="/wiki/Subcutaneous_T-cell_lymphoma" title="Subcutaneous T-cell lymphoma">Subcutaneous T-cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">By infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Human_T-lymphotropic_virus_1" title="Human T-lymphotropic virus 1">HTLV-1</a></i> (<a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">NK cell</a>/<br />
(most <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Aggressive_NK-cell_leukemia" title="Aggressive NK-cell leukemia">Aggressive NK-cell leukemia</a></li>
<li><a href="/wiki/Blastic_NK_cell_lymphoma" title="Blastic NK cell lymphoma">Blastic NK cell lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">T or NK</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus" class="mw-redirect">EBV</a></i> (<a href="/wiki/Extranodal_NK-T-cell_lymphoma" title="Extranodal NK-T-cell lymphoma" class="mw-redirect">Extranodal NK-T-cell lymphoma</a>/<a href="/wiki/Angiocentric_lymphoma" title="Angiocentric lymphoma" class="mw-redirect">Angiocentric lymphoma</a>)</li>
<li><a href="/wiki/Large_granular_lymphocytic_leukemia" title="Large granular lymphocytic leukemia">Large granular lymphocytic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Lymphoid+myeloid</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lymphocytosis" title="Lymphocytosis">Lymphocytosis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative disorders</a> (<a href="/wiki/X-linked_lymphoproliferative_disease" title="X-linked lymphoproliferative disease">X-linked lymphoproliferative disease</a></li>
<li><a href="/wiki/Autoimmune_lymphoproliferative_syndrome" title="Autoimmune lymphoproliferative syndrome">Autoimmune lymphoproliferative syndrome</a>)</li>
<li><a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">Leukemoid reaction</a></li>
<li><a href="/wiki/Diffuse_infiltrative_lymphocytosis_syndrome" title="Diffuse infiltrative lymphocytosis syndrome">Diffuse infiltrative lymphocytosis syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia" title="Cutaneous lymphoid hyperplasia">Cutaneous lymphoid hyperplasia</a>
<ul>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_bandlike_and_perivascular_patterns" title="Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns" class="mw-redirect">with bandlike and perivascular patterns</a></li>
<li><a href="/wiki/Cutaneous_lymphoid_hyperplasia_with_nodular_pattern" title="Cutaneous lymphoid hyperplasia with nodular pattern" class="mw-redirect">with nodular pattern</a></li>
</ul>
</li>
<li><a href="/wiki/Jessner_lymphocytic_infiltrate_of_the_skin" title="Jessner lymphocytic infiltrate of the skin" class="mw-redirect">Jessner lymphocytic infiltrate of the skin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Immunoproliferative_immunoglobulin_disorders" title="Template talk:Immunoproliferative immunoglobulin disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Immunoproliferative_immunoglobulin_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Immunoproliferative_disorder" title="Immunoproliferative disorder">Immunoproliferative</a> <a href="/wiki/Antibody" title="Antibody">immunoglobulin</a> disorders (<a href="/wiki/ICD-10_Chapter_III:_Diseases_of_the_blood_and_blood-forming_organs,_and_certain_disorders_involving_the_immune_mechanism#.28D80.E2.80.93D89.29_Certain_disorders_involving_the_immune_mechanism" title="ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism">D89</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">273</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a></li>
<li><a href="/wiki/Multiple_myeloma" title="Multiple myeloma">Multiple myeloma</a> (<a href="/wiki/Plasma_cell_leukemia" title="Plasma cell leukemia">Plasma cell leukemia</a>)</li>
<li><a href="/wiki/Monoclonal_gammopathy_of_undetermined_significance" title="Monoclonal gammopathy of undetermined significance">MGUS</a></li>
<li><i><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></i> (<a href="/wiki/Macroglobulinemia" title="Macroglobulinemia">Macroglobulinemia</a>/<strong class="selflink">Waldenström's macroglobulinemia</strong>)</li>
<li><i><a href="/wiki/Immunoglobulin_heavy_chain" title="Immunoglobulin heavy chain">heavy chain</a></i> (<a href="/wiki/Heavy_chain_disease" title="Heavy chain disease">Heavy chain disease</a>)</li>
<li><i><a href="/wiki/Immunoglobulin_light_chain" title="Immunoglobulin light chain">light chain</a></i> (<a href="/wiki/AL_amyloidosis" title="AL amyloidosis">Primary amyloidosis</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other <a href="/wiki/Hypergammaglobulinemia" title="Hypergammaglobulinemia">hypergammaglobulinemia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cryoglobulinemia" title="Cryoglobulinemia">Cryoglobulinemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lymph_immune_and_complement_navs" title="Template:Lymph immune and complement navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lymph_immune_and_complement_navs" title="Template talk:Lymph immune and complement navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lymph_immune_and_complement_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Immune_system" title="Immune system">immune system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Lymphocytic_immune_system" title="Template:Lymphocytic immune system">Physiology</a>
<ul>
<li><a href="/wiki/Template:Lymphocytes" title="Template:Lymphocytes">cells</a></li>
<li><a href="/wiki/Template:Autoantigens" title="Template:Autoantigens">autoantigens</a></li>
<li><a href="/wiki/Template:Autoantibodies" title="Template:Autoantibodies">autoantibodies</a></li>
<li><a href="/wiki/Template:Complement_system" title="Template:Complement system">complement</a></li>
<li><a href="/wiki/Template:Surface_antigens" title="Template:Surface antigens">surface antigens</a></li>
<li><a href="/wiki/Template:Immunoglobulin_superfamily_immune_receptors" title="Template:Immunoglobulin superfamily immune receptors">IG receptors</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Allergic_conditions" title="Template:Allergic conditions">Allergies</a></li>
<li><a href="/wiki/Template:Lymphoid_and_complement_immunodeficiency" title="Template:Lymphoid and complement immunodeficiency">Immunodeficiency</a></li>
<li><a href="/wiki/Template:Immunoproliferative_immunoglobulin_disorders" title="Template:Immunoproliferative immunoglobulin disorders">Immunoproliferative immunoglobulin disorders</a></li>
<li><a href="/wiki/Template:Hypersensitivity_and_autoimmune_diseases" title="Template:Hypersensitivity and autoimmune diseases">Hypersensitivity and autoimmune disorders</a></li>
<li><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy">Neoplasms and cancer</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Immunologic_techniques_and_tests" title="Template:Immunologic techniques and tests">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antihistamines" title="Template:Antihistamines">antihistamines</a></li>
<li><a href="/wiki/Template:Immunostimulants" title="Template:Immunostimulants">immunostimulants</a></li>
<li><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants">immunosuppressants</a></li>
<li><a href="/wiki/Template:Monoclonals_for_immune_system" title="Template:Monoclonals for immune system">monoclonal antibodies</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1256
CPU time usage: 0.642 seconds
Real time usage: 0.844 seconds
Preprocessor visited node count: 6658/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 561689/2097152 bytes
Template argument size: 2776/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 37/500
Lua time usage: 0.253/10.000 seconds
Lua memory usage: 2.92 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  742.008      1 - -total
 71.50%  530.544      1 - Template:Reflist
 37.65%  279.345     28 - Template:Cite_pmid
 26.36%  195.563     53 - Template:Cite_journal
 18.34%  136.101     10 - Template:Navbox
 10.74%   79.728      9 - Template:Cite_doi
  9.55%   70.857      1 - Template:Infobox_disease
  8.68%   64.383      1 - Template:Hematological_malignancy_histology
  8.37%   62.126      1 - Template:Infobox
  4.36%   32.331      5 - Template:Cite_book
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:2898867-0!*!0!!en!*!* and timestamp 20150710173407 and revision id 670374383
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Waldenström%27s_macroglobulinemia&amp;oldid=670374383">https://en.wikipedia.org/w/index.php?title=Waldenström%27s_macroglobulinemia&amp;oldid=670374383</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Rare_cancers" title="Category:Rare cancers">Rare cancers</a></li><li><a href="/wiki/Category:Hematologic_malignant_neoplasms" title="Category:Hematologic malignant neoplasms">Hematologic malignant neoplasms</a></li><li><a href="/wiki/Category:Vascular-related_cutaneous_conditions" title="Category:Vascular-related cutaneous conditions">Vascular-related cutaneous conditions</a></li><li><a href="/wiki/Category:Lymphoma" title="Category:Lymphoma">Lymphoma</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Waldenstr%C3%B6m%27s+macroglobulinemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Waldenstr%C3%B6m%27s+macroglobulinemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Waldenstr%C3%B6m%27s_macroglobulinemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Waldenstr%C3%B6m%27s_macroglobulinemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Waldenstr%C3%B6m%27s_macroglobulinemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;oldid=670374383" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1778287" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;id=670374383" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Waldenstr%C3%B6m%27s+macroglobulinemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Waldenstr%C3%B6m%27s+macroglobulinemia&amp;oldid=670374383&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D9%81%D8%A7%D9%84%D8%AF%D9%86%D8%B4%D8%AA%D8%B1%D9%88%D9%85" title="مرض فالدنشتروم – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Macroglobulin%C3%A8mia_de_Waldenstr%C3%B6m" title="Macroglobulinèmia de Waldenström – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Waldenstr%C3%B6ms_makroglobulin%C3%A6mi" title="Waldenströms makroglobulinæmi – Danish" lang="da" hreflang="da">Dansk</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Morbus_Waldenstr%C3%B6m" title="Morbus Waldenström – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Macroglobulinemia_de_Waldenstrom" title="Macroglobulinemia de Waldenstrom – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Maladie_de_Waldenstr%C3%B6m" title="Maladie de Waldenström – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Macroglobulinemia_de_Waldenstr%C3%B6m" title="Macroglobulinemia de Waldenström – Galician" lang="gl" hreflang="gl">Galego</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Macroglobulinemia_di_Waldenstr%C3%B6m" title="Macroglobulinemia di Waldenström – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Limfoplazmocitin%C4%97_limfoma" title="Limfoplazmocitinė limfoma – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Ziekte_van_Waldenstr%C3%B6m" title="Ziekte van Waldenström – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Makroglobulinemia_Waldenstr%C3%B6ma" title="Makroglobulinemia Waldenströma – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Macroglobulinemia_de_Waldenstr%C3%B6m" title="Macroglobulinemia de Waldenström – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9C%D0%B0%D0%BA%D1%80%D0%BE%D0%B3%D0%BB%D0%BE%D0%B1%D1%83%D0%BB%D0%B8%D0%BD%D0%B5%D0%BC%D0%B8%D1%8F_%D0%92%D0%B0%D0%BB%D1%8C%D0%B4%D0%B5%D0%BD%D1%81%D1%82%D1%80%D1%91%D0%BC%D0%B0" title="Макроглобулинемия Вальденстрёма – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Makroglobulinemi" title="Makroglobulinemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1778287#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 7 July 2015, at 15:38.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Waldenstr%C3%B6m%27s_macroglobulinemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":101,"wgHostname":"mw1151"});
}</script>
	</body>
</html>
